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Abstract
Vascular tissue engineering aims to design more reliable substitutes for diseased
or otherwise failed blood vessels. For this approach to be successful, the engineered
blood vessel must provide similar structure and integrity to that of the native vascular
tissue. Despite extensive studies documented in scientific literature, the designing of
clinically-relevant vascular tissue has been largely unsuccessful. One of the challenges is
our lack of understanding on how vascular smooth muscle cells (VSMCs) and vascular
endothelial cells (VECs) interact in the graft. The objective of this study was to examine
the factors that play a role in VSMC and VEC interaction in 3D co-culture so that a
compliant graft can be constructed. Highly porous 3D poly(carbonate urethane) (PCU)
scaffolds were fabricated using a solvent casting particulate leaching method. Human
coronary artery smooth muscle cells (HCASMCs) and human coronary artery endothelial
cells (HCAECs) were seeded sequentially on scaffolds containing basal and medial
adhesion protein layers. Co-cultures were carried out and stained to allow observation of
cell orientation and morphology. Results showed that HCASMCs readily attached to the
scaffold and formed dense confluent layers which facilitated the attachment and
organization of HCAECs into a monolayer above the HCASMC layer. In addition, the
HCAECs showed a greater affinity toward the HCASMCs than to the scaffold. Western
blot analysis showed that co-culture induced an up-regulation of the contractile
phenotype in HCASMCs as well as the Notch3 receptor and its ligand Jagged1. In order
to identify the link between Jagged1 and the expression of contractile proteins a Jagged 1
knockdown study was conducted using small interfering RNA (siRNA). Results showed
a reduction in smooth muscle α-actin and calponin in co-cultures treated with Jagged1
iii

siRNA compared with expression levels in co-cultures treated with control siRNA. It can
therefore be concluded that the Jagged1-Notch3 pathway is an important regulator of
VSMC phenotype and can be taken advantage of when fabricating engineered tissues.

Keywords: tissue engineering, vascular smooth muscle cell, vascular endothelial cell, coculture, polyurethane scaffolds, phenotype modulation, contractile protein expression,
Notch signaling, Jagged1
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Chapter 1 - Introduction
1.1 Overview
One of the strongest motivators behind the field of vascular tissue engineering is
the ever-present incidence of coronary artery disease (CAD). Cardiovascular diseases- of
which CAD comprises the majority- are currently the number one cause of death
worldwide1 and are projected to increase in prevalence with the aging of the baby boomer
population and a growing incidence of diabetes2. Autologous vessels are the most reliable
option for the replacement of diseased coronary arteries and as such are the most
frequently used. Graft vessels are generally harvested from the internal mammary artery
(IMA), saphenous vein (SV) or the internal thoracic artery3. The structure of the IMA
matches well with that of the coronary artery and thus it provides a much more patent
graft vessel as compared with the SV4. In addition to concerns with patency, the source
for viable graft vessels may be depleted in many patients5-6. These individuals have the
option of having a synthetic graft implanted; however, these grafts are accompanied by a
high risk of bacterial infection, intimal hyperplasia and thrombus formation. Furthermore,
their noncompliance with the native artery contributes to their limited use as coronary
artery bypass grafts (CABGs)7. The emergence of vascular tissue engineering is triggered
by the lack of major advancements in current therapies as a means to overcome the
drawbacks that they present. In view of this, tissue engineering aims to produce
functional living substitutes. The fundamental stages in the fabrication of a tissue
engineered vascular substitute are: (1) expansion of cells and infiltration into a scaffold,
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(2) maturation of the cell-scaffold construct to achieve the necessary mechanical and
biological properties and (3) surgical implantation into the host8. Success with smalldiameter tissue engineered vascular grafts (TEVGs) has been limited and is attributed to a
mismatch in compliance with the adjacent artery, misalignment of smooth muscle cells
(SMCs) and insufficient amounts of elastin, collagen and SMCs9. These critical
components can in principle be enhanced through strategic manipulation of SMC
phenotype and it has been largely acknowledged that phenotype switching at the
appropriate maturation stage would produce a TEVG that emulates the native tissue in
structure, function and composition10-11. Investigators have sought to understand the role
of various factors in the modulation of SMC phenotype including: matrix components,
growth factors, scaffold geometry, mechanical stimulation and endothelial cell (EC)SMC interactions9. Much of the work completed thus far in the investigation of SMC in
co-culture with EC has either relied on models that do not accurately represent the native
in vivo conditions, has used exogenous stimuli that are inapplicable to tissue engineering
applications or has assessed the production of matrix molecules in co-culture. However, a
direct dependence of SMC phenotype on the presence of ECs has also been reported in
literature12-13 and some of the mechanisms governing their interactions have started to
emerge14-16. A deeper understanding of these mechanisms in the context of threedimensional (3D) engineered vasculature may enable their exploitation in the creation of
more physiologically accurate substitutes.
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1.2 Thesis Outline
This thesis contains five chapters that detail the work carried out in the
investigation of the interactions between vascular cells in 3D polyurethane scaffolds.
Chapter 2 introduces the basis for vascular tissue engineering, illustrates the motivation
for this study and outlines its specific objectives. The materials and experimental
methodologies used are described in Chapter 3 and are followed by the significant
findings of this work in Chapter 4. Chapter 5 summarizes the results and provides the
significance and future directions of this project.
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Chapter 2 - Literature Review

2.1 Structure and Function of Blood Vessels
Blood vessels are complex networks of hollow tubes with distinct structures that
allow them to transport blood throughout the body. Oxygenated blood is pumped by the
heart into the aorta which distributes the blood to large arteries. From here the blood is
dispersed to smaller arteries, arterioles and finally capillaries where nutrient, oxygen and
waste exchange occurs to and from tissues and organs. Venules then carry the oxygendepleted blood to larger veins and finally back to the heart1. Apart from small arterioles
and capillaries, vessels are constructed of three distinct concentric layers that vary in
thickness depending on the location of the vessel and its function1-2. The inner most layer
that contacts the blood is the tunica intima and consists of a lining of ECs attached to a
basement membrane of extracellular matrix (ECM) proteins1. Adjacent to the intima is
the tunica media˗ a densely packed layer of SMCs. These SMCs are oriented
circumferentially into dense layers with fenestrated elastic lamellae interspersed between
them1,3. Veins do not function in a primarily contractile manner and so have a much
thinner tunica media than do arteries. The outermost layer is the tunica adventitia and is
composed of fibroblasts and a collagenous ECM2 that protects and reinforces the blood
vessel and anchors it to the surrounding tissue. Nerves and lymphatic vessels infiltrate the
adventitia and provide further structural support3. In addition, arteries have an internal
and external elastic lamina. The medial layer is bound by the elastic laminae where the
majority of the elastin is concentrated4. The elastic tissue aids the vessel wall in
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maintaining its resilience3 and imparts arterial elasticity under pulsatile flow5. The
structure of an artery wall is shown in Figure 2.1.

Figure 2.1: Structure of the artery wall2. (A) Organization of the intima, media and adventitia.
(B) Cross-sectional view showing the organization of elastin in the media of muscular arteries
(left) and elastic arteries (right).

The endothelial monolayer was once thought to be a passive lining of the
vasculature, but it is now known that it serves several important functions such as the
prevention of thrombus formation, coagulation and intimal hyperplasia6. Under
physiological conditions the glycocalyx layer on the ECs cells in conjunction with nitric
oxide and prostacyclin prevent platelet adhesion7-8. Additionally, ectonucleotidases on
the endothelial cell surface metabolize adenosine diphosphate which inhibits platelet
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recruitment. Coagulation is initiated by the exposure of tissue factor to blood and
progresses as fibrinogen is converted to fibrin by thrombin. Under normal conditions
endothelial cells inhibit the tissue factor expression pathway and produce
thrombomodulin which deactivates thrombin, thereby preventing the onset of
coagulation6. Thrombus formation is also suppressed by the binding of antithrombin III
to heparin sulfate proteoglycans. In the event that coagulation does occur, the endothelial
cells release tissue type plasminogen activator to break up the fibrin clots7. Intimal
hyperplasia is averted through the release of molecules that prevent SMC differentiation.
The intact EC layer also controls the movement of molecules through the vascular wall,
regulates vasomotor tone and maintains homeostatis of the vessel3.

The function of the SMCs that populate the tunica media is to regulate the flow of
blood. These cells are capable of shifting between a contractile phenotype, found in
physiological conditions, and a synthetic phenotype which is characteristic of
pathological conditions. In the contractile phenotype SMCs dilate and contract in a
coordinated manner to increase or decrease the vessel diameter, thereby changing the
flow of blood through the lumen2. Vasoactivity is modulated primarily by the SMCs and
the neighboring ECs. The VSMCs receive neuronal or hormonal signals from the
endothelial monolayer and react by generating the appropriate contractile force to meet
the necessary blood pressure. Cells in the contractile phenotype have a spindle-shaped
morphology, a centrally located nucleus and proliferate at a very low rate. This
morphology can quickly transform to that of a fibroblast’s upon stimulation by
pathological conditions. This state is known as the synthetic phenotype and is
characterized by high levels of ECM production and proliferation7.
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The mechanical properties of the blood vessel arise from a network of ECM
component, namely: collagen (types I and III), fibrous elastin, proteoglycans (versican,
decorin, biglycan, lumican, perlican), hyaluronan, and glycoproteins (laminin,
fibronectin, thrombospondin, tenascin)1. Properties such as tensile stiffness, elasticity and
incompressibility are imparted by collagens, elastin and proteoglycans respectively, while
viscoelasticity is provided by the combination of all three1-2. The composition and
organization of the ECM and the interactions between these proteins and the cells
determine the degree of mechanical functioning in the blood vessel. Additionally, these
proteins provide anchorage to the cells, and guide the biological functions of the tissue
under both physiological and pathological conditions. This is achieved through bioactive
domains on ECM molecules that can bind to structural or connecting proteins, signaling
molecules (growth factors, cytokines, chemokines, and matrix proteinases) and
membrane receptors.

Upon binding to cell surface receptors, intracellular signaling

pathways can be activated or deactivated via either biochemical cues or
mechanotransduction3.

The internal and external elastic laminae have a convoluted structure that arises
during vasculogenesis. A recent study9 of elastin fiber organization in rabbit aorta has
shown that whereas the internal elastic laminae supports loading in the longitudinal
direction – that is stretching along the vessel axis- , the external elastic laminae supports
circumferential loading – that is stretching in the radial direction. At low strains, the
elastin stretches for the duration of the pulse and returns to its original state as the pulse
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wanes. These properties are critical since pressure waves arising from pulsatile blood
flow act in both the radial and longitudinal directions4. The elastin molecules in the
laminae also convey signals between the media and intima to regulate the phenotypic
modulation, proliferation and organization of VSMCs and so are critical components of
the arterial structure2.

2.2 Coronary Arteries
Coronary arteries have the same distinct structure as depicted in Figure 1;
however, because they are considered to be muscular arteries, their medial layer
constitutes the bulk of the arterial wall (left side of Figure 2.1B). Typically their internal
diameter ranges from 3 to 4 mm with a wall thickness of 1 mm. Muscular arteries
transport blood to organs at high pressures (80-120 mmHg) and experience shear stresses
in the range of 0.75-2.25 Pa during a single cardiac cycle3. The pumping heart undergoes
large deformations and so the coronary arteries are subjected to larger longitudinal strains
and smaller circumferential wall strains (10-15%)10-11. The elastic laminae surrounding
the tunica media allow the artery to recoil and prevent vascular dilation that would result
from the creep of collagen under high blood pressures. For human coronary arteries, the
burst pressure is about 2000 mm Hg (266 kPa)3. The coronary arteries originate at the
root of the aorta and split into two branches that vascularize the myocardium. The left
coronary artery supplies blood to the left atrium and left ventricle of the heart, while the
right coronary artery supplies blood to the right atrium and right ventricle of the heart12.
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2.3 Diseases of the Coronary Artery
According to recent data, cardiovascular diseases – of which CAD comprises the
majority- are the prevailing cause of death worldwide13. Incidences of CAD are expected
to rise over the next 15 years due to increasing prevalence in developing countries and
Eastern Europe as well as an increasing prevalence of obesity and diabetes14 which can
lead to cardiovascular complications4. CAD most commonly arises from atherosclerosis,
an inflammatory disease. It is initiated by injury (for example- high cholesterol or
glucose, smoking and high blood pressure) to the endothelial lining of the blood vessel
and eventually results in the formation of a complex lesion in the artery wall15. At
physiological conditions, low density lipoprotein (LDL) in the blood infiltrates through
the intima and is mostly eliminated on the abluminal side of the artery wall, though some
of it is retained. In periods of hypercholestoremia, circulating levels of LDL are elevated.
Accumulation of these molecules is facilitated by proteoglycans, of the ECM, which bind
the LDL molecules. Subsequent oxidation of LDL particles results in the release of
phospholipids that activate the endothelium16. ECs then upregulate expression of vascular
cell adhesion molecule-1 (and various others) which recruit monocytes, lymphocytes,
macrophages and mast cells (immune cells) causing them to adhere to these sites15.
Chemokines produced in the intima stimulate their migration to the subendothelial
space17-18. Monocytes then transform into macrophages which engulf the oxidized LDL
particles and become foam cells17,19 while molecules such as platelet derived growth
factor (PDGF), tumor necrosis factor (TNF) and interleukins change the qualitative
composition of the ECM and induce phenotypic modulation of the VSMCs15. As foam
cells rupture they release their lipid contents developing a lipid necrotic core which
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continues to grow as SMCs migrate to the intima, proliferate and secrete ECM proteins
that form a fibrous cap around the core15, 19-21. If unabated, this inflammatory response
continues resulting in narrowing of the lumen which is compensated for by gradual
dilation. However, it reaches a point where the lumen narrows so much that the flow of
blood is altered to the succeeding tissues resulting in ischemia (inadequate blood supply
to the heart). Furthermore, if the plaque becomes unstable and ruptures, coagulation is
initiated resulting in a deep thrombus formation that can occlude the blood vessel leading
to acute myocardial damage19,21.

2.4 Surgical Interventions
CABGs are the gold standard for treatment of diseased coronary arteries and as
such are the most frequently used surgical intervention. Grafts of principally autologous
tissue from the IMA, SV or internal thoracic artery are used. Although these vessels are
considered of highest quality, they present several unresolved concerns. SV grafts from
elderly patients are prone to thrombus and neointima formation as well as atherosclerosis
and aneurysms upon implantation at high pressure locations22. On average, patency rates
after ten years tend to be high for IMA grafts but approximately 50% of SV grafts
become occluded as a result of neo-intima formation23. The IMA is structurally more
similar to the coronary artery than the SV (which tends to distend excessively resulting in
failure23-24) and thus has a higher likelihood of remaining patent. In many patients (3050%), however, the supply of viable autologous vessels may not be sufficient due to their
use in prior surgeries25-26. Additionally, the graft vessel may be diseased, rendering it
unusable, or may not match the compliance of the target artery3, 4. Autologous vessels
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commonly become thrombogenic causing SMCs to proliferate and migrate to the intima
resulting in restenosis and eventual graft failure27. Recent studies have shown that SV
graft failure may be reduced up to 70% with the insertion of stent28-29. Donor site
morbidity is another serious complication of using vein grafts. Although the option of
using allografts (same species but different donor) and xenografts (different species)
exists, it is accompanied by a high risk of immune rejection and pathogen transmission15.
Moreover, allografts have been associated with EC sloughing and reaction with
leukocytes, poor patency, rejection and a loss of vascular reactivity; thus, they are no
longer in use for by-pass surgery30. Patients who do not have available autologous tissue
may

receive

a

prosthetic

graft.

Synthetic

materials

such

as

expanded

polytetrafluoroethylene (ePTFE) , and polyethylene teraphthalate (PET), also known as
Dacron, have seen some success in large-diameter vessel replacement but have major
flaws that limit their use in small-diameter, low flow vessels, like the coronary artery.
These include compliance mismatch between the graft and native artery (due to a lack of
viscoelasticity in the synthetic material), intimal hyperplasia especially around the
anastomoses (location of suture), risk of bacterial infection (the graft may harbor
bacteria) and thrombus formation on the internal surface of the graft30 (due to the lack of
an endothelial lining)31. The continuous endothelial lining is an essential component of
the graft as it provides a selectively permeable, anti-thrombotic barrier between the blood
and artery wall by controlling platelet activation and adhesion32, and leukocyte
adhesion33. Additionally, ECs regulate the vascular tone34 and SMC behaviour35. In larger
artery replacements the endothelial lining is not as critical for long-term patency because
the high blood flow rate does not allow platelets sufficient time to adhere to the graft. In
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vessels such as the coronary artery however, the flow is markedly slower allowing
immune cells to accumulate on the lumen of the graft15. Unfortunately, unlike what is
observed in animal models, these grafts do not spontaneously endothelialize in humans36.
In vitro seeding of ECs onto ePTFE grafts prior to use in coronary by-pass surgery has
improved its long term patency to 91% at 2.5 years (for 4 mm diameter grafts) and 65%
at 9 years (for 5 mm diameter grafts) compared with an average patency of 54% at 4
years for non-endothelialized grafts. However, this approach requires a long culture
period (2-4 weeks) prior to implantation27. Synthetic grafts also require extensive use of
anticoagulant/ antithrombotic therapy to suppress immune rejection, which can have
negative side effects15,30.

Several non-invasive therapeutic options have emerged in recent years for the
treatment of atherosclerosis. These include immunosuppressive drugs such as
cyclosporine and sirolimus (also used for coating stents that are implanted for the
treatment of post-angioplasty restenosis) which block T-cell activation, smooth muscle
cell proliferation and inhibit intimal lesions. However, their efficacy in treating coronary
syndromes is unknown. Results from the use of vaccination with oxidized LDL, bacteria
containing modified phospholipids, or heat-shock protein 60 have been encouraging but
additional elucidation is needed before they can be tested in humans17.

Although significant progress has been made in the quality of therapies available
there are still many challenges to overcome. Whilst life expectancy among afflicted
individuals has improved and mortality rates have decreased as a result of advancements
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in therapeutic treatments, the burden of disease still exists and may actually have
increased. CAD can develop into a chronic condition if the implanted graft does not
remain patent and repeated failures occur. In addition to the psychological impact of the
disease they endure, many of these individuals live a debilitating lifestyle and have
difficulty performing menial tasks. Thus the need for an alternative vascular replacement
is urgent and indisputable37. Tissue engineering is one such alternative with great
potential for providing a source of replacement vessels1.

2.5 Vascular Tissue Engineering
Over the last few decades tissue engineering has emerged to offer an alternative
means of addressing the short comings of current therapies such as immune rejection and
unavailability. Broadly defined, tissue engineering is “the application of principles and
methods of engineering and life sciences toward fundamental understanding of structurefunction relationships in normal and pathological mammalian tissues and the
development of biological substitutes to restore, maintain, or improve tissue function”38.
The most widely used paradigm of tissue engineering (shown in Figure 2.2)
involves the seeding of cells onto a scaffold (of natural or synthetic composition),
maturation of cell-scaffold constructs in a metabolically and mechanically supportive
environment (bioreactor) and the subsequent implantation of the engineered tissues to the
appropriate anatomical location.
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Figure 2.2: Tissue engineering paradigm showing the essential stages. Autologous cells are
first harvested and expanded in vitro. This is followed by seeding of cells onto a natural or
synthetic scaffold and maturation of the construct in a bioreactor. The engineered tissue is then
implanted at the appropriate anatomical location.

Once implanted, further remodeling allows tissue integration with the host
tissue39. The various elements for successful tissue engineering are discussed below.

2.5.1 Cell Source
A variety of primary cell sources can be used for creating engineered tissues.
Each has limitations and risks but can also offer unique advantages. Autologous cells are
those that are harvested from the same patient into which the final tissue will be
implanted. The advantage of using autologous cells is that they minimize the risk of
inciting an adverse host immune response as well as the risk of disease transmission40.
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The drawback is that these cells (especially from elderly patients) may be unavailable,
have low proliferative capacity, require long expansion periods and have high
variability39. Allogeneic cells are harvested from the same species but a different donor
while xenogeneic cells come from a different species altogether. Both allogeneic and
xenogeneic cells offer the advantage of creating engineered tissue banks that eliminate
waiting times; however, their use is complicated by the risk of disease transmission and
adverse host immune response40-41. Other potential sources of cells are adult stem cells,
bone marrow stromal cells, bone marrow-dervied circulating stem cells and pluripotent
embryonic stem cells39.

2.5.2 Scaffolds
Scaffolds are used to provide a 3D template to guide tissue generation and mimic
the functions of native ECM. Because most primary cells are anchorage-dependant, they
require a supporting material for survival and growth42. Scaffolds support cell adhesion,
migration, proliferation, differentiation and contribute to the initial and/or final
mechanical properties of the tissue. It has been shown that scaffold composition,
degradation and architecture influence cell behaviour4,43. Scaffolds may be composed of
natural or synthetic materials. Synthetic materials can be functionalized with bioactive
ligands to deliver growth factors and signals or to direct 3D cell orientation. Upon
implantation, if the scaffold is biostable, it also facilitates spatial arrangement of cells
under aggressive in vivo conditions and contributes to the mechanical properties of the
graft. Desirable characteristics of a scaffold are biocompatibility and biodegradability.
Ideally, the scaffold should degrade at a rate that does not compromise the function of the
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tissue while cells simultaneously go through the process of creating their own ECM to
replace the scaffold44. However, commonly used biodegradable polymers (poly(L-lactic
acid) (PLLA) and poly(glycolic acid) (PGA)) for vascular tissue engineering tend to
generate acidic degradation products45-46 that adversely affect VSMC behaviour47.

2.5.3 The Role of Bioreactors
Bioreactors play an important role in the maturation of engineered tissue. They
supply the growing tissue with the necessary biochemical stimuli, such as oxygen and
growth factors, and mechanical stimuli, such as tension, compression and shear, to mimic
in vivo conditions. In the context of vascular tissue engineering this is a critical stage that
promotes uniform cell distribution48, alignment, proliferation and secretion of ECM
components. Such stresses have been shown to improve the structural and mechanical
properties of engineered tissues39.

2.5.4 Implantation and Remodeling
Remodeling by the host is often viewed as essential and beneficial stage of tissue
engineering49.

Upon implantation, even autogolous constructs will induce immune

reactions and undergo remodeling50. This process can affect the functioning of the
construct and may facilitate its successful integration into the surrounding tissue44. The
degree to which a tissue engineered vascular grafts is remodeled is of critical importance.
Excessive remodeling is undesirable as it can lead to intimal hyperplasia and restenosis
after grafting4.
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2.5.5 Applications of Tissue Engineering
Tissue engineering allows for the fabrication of tailored blood vessels that
respond to both mechanical and biological cues allowing them to easily acclimate to the
native hemodynamic environment. They also have the ability to remodel, grow and
repair, making them appealing for use in pediatric patients51-52. Apart from the obvious
application of engineered tissues as replacement vessels, they can also serve as tools for
studying normal physiological processes and pathogenesis of diseases. Furthermore, they
can allow us to study the responses of tissue to injury, the toxicity of drugs on tissues and
contractile responses in vascular tissues, enhance cell-based drug discovery and study
interactions between cells and between cells and their surrounding matrix. Some
examples of tissue engineered products that are currently in use or in development
include: replacement skin, biohybrid extracorporeal artificial organs, cartilage
regeneration using autolougous chondrocyte transplantation and a replacement thumb39.
This shows the great potential of tissue engineering and the promise it holds as an
alternative treatment modality.

2.6 Missing Elements of Current TEVGs
Despite the rapid progress that has been made in the field of vascular tissue
engineering there are still several factors limiting graft function. Unlike other tissue
engineering approaches, vascular grafts cannot rely on in vivo remodeling to approach
functionality with time. They are designed to be implanted into demanding and dynamic
environments and so must function immediately upon implantation. Some of the
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requirements of engineered vascular grafts include: appropriate burst strength to
withstand changes in blood pressure, matching compliance to the adjacent vessel,
appropriate elasticity to withstand cyclic loading and a nonthrombogenic lining1. Many of
these mechanical properties are imparted by the ECM proteins collagen and elastin.
Indeed, a critical factor in the failure of current engineered conduits is a lack of these
proteins. Furthermore, misalignment of SMCs in the longitudinal direction and low SMC
numbers have also been identified as limiting factors of graft performance.

These

problems can essentially be resolved with proper regulation of SMC phenotype4. For this
reason, a key research area in the fabrication of small diameter blood vessels is the
plasticity of smooth muscle cells30,53. Both the synthetic and contractile phenotypes of
VSMCs are needed for vascular tissue engineering in order to produce a graft that
emulates the in vivo composition, morphology and function4. The following section
elaborates on vascular smooth muscle cell modulation with accompanying literature.

2.7 VSMC Phenotype and Relevant Co-culture Studies
2.7.1 VSMC Phenotype
Despite the urgent need for a tissue engineered blood vessel, there are still several
outstanding issues to resolve. Among these is the regulation of VSMC phenotype in 3D
culture. VSMCs are known to exhibit remarkable plasticity in their native in vivo
environment. One of the challenges in understanding the differentiation process that they
undergo is that SMCs are present in a distinct synthetic and contractile phenotype as well
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as a wide spectrum of phenotypes in between. These phenotypes are reversible and are a
function of changing local environmental cues4,54-55. For example, during vasculogenesis
SMCs are highly proliferative and migratory and lay down an abundance of ECM
molecules such as collagen, elastin, proteoglycans, cadherins and integrins which
constitute a majority of the blood vessel’s composition54. A critical step in vasculogenesis
is the formation of gap junctions with ECs; these junctions play a major role in vessel
maturation and remodeling56. Mature SMCs on the other hand acquire a contractile
phenotype that is marked by a very low proliferative index, extremely low synthetic
activity and expression of an array of contractile proteins, receptors, ion channels,
calcium regulatory proteins and signaling molecules that are essential to the contractile
activity of the cells57. Smooth muscle α-actin (SM-α-actin), smooth muscle myosin heavy
chain (MHC), smoothelin-B, h-caldesmon and calponin are among the cytoskeletal
proteins expressed by these cells58. The principle function of mature SMCs is the
regulation of vessel tone-diameter, blood pressure and blood flow distribution54. The
characteristic morphology of contractile VSMCs is spindle-like. This allows them to pack
together into dense, circumferentially aligned layers that can translate individual
contractions and dilations into macroscopic ones4. A unique characteristic of SMCs is
that unlike skeletal or cardiac muscle cells, they are non-terminally differentiated, that is
they have the ability to shift between phenotypes. Therefore, although these cells perform
predominantly contractile functions they can easily revert to the synthetic phenotype if
exposed to certain biochemical or biomechanical stimuli56,58. The transition to a synthetic
phenotype involves suppression of genes that encode for contractile marker proteins and
a pronounced increase in expression of genes that promote proliferation and matrix
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turnover such as metalloproteinases and l-caldesmon54,59. The synthetic phenotype of
mature SMCs is somewhat akin to the embryonic and fetal vascular smooth muscle
phenotype60-61. Morphologically, cells in the synthetic phenotype resemble fibroblasts,
have an extensive endoplasmic reticulum and few myofilaments. Furthermore, actin is
present predominantly in the non-muscle p-form62. It is thought that the plasticity of
SMCs has evolved as a survival mechanism and that mutations that hampered the ability
of these cells to participate in vascular repair would have been detrimental and eventually
diminished54-55. There are however, negative consequences to this, since SMCs will
adversely switch phenotypes in the presence of abnormal environmental cues. Dedifferentiation (shifting to synthetic phenotype) plays a key role in the development
and/or progression of several diseases such as cancer, hypertension, and most notably
atherosclerosis54. The phenotypic characteristics of VSMCs are illustrated in Figure 2.3
below.

Figure 2.3: Vascular smooth muscle morphology in physiological and pathological states4.
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2.7.2 VSMC Phenotype Modulation in TEVGs
The phenotype shifting property of VSMCs is considered of paramount
importance in the construction of a functioning vasculature. Initially, the synthetic
phenotype is desired to enable the cells to expand rapidly in culture. This would in turn
promote infiltration and population of the scaffold by the VSMCs to create dense cell
layers. This proliferation phase would also result in the secretion of appropriate ECM
components to provide the tissue engineered vessel with sufficient mechanical properties
and to provide a substrate for EC adhesion. Once the desired population of cells is
achieved, the cells must then shift to a quiescent contractile phenotype to impart the
vasoactive properties found in native blood vessels. Furthermore, the VSMCs must
organize themselves circumferentially in order to constrict and dilate the construct in the
necessary direction and to improve the mechanical properties4. Failure of the cells to
differentiate would, upon implantation, result in the onset of intimal hyperplasia and
restenosis, resulting in immediate graft failure58. It has been noted that significant causes
of graft failure are misalignment of SMCs in the longitudinal direction, insufficient
amounts of collagen, elastin and SMCs, all of which can be manipulated through the
strategic regulation of VSMC phenotype4. Premature graft implantation causes SMCs to
continually proliferate, thereby thickening the vessel wall and narrowing the lumen.
VSMC phenotype switching from synthetic to contractile is considered crucial for the
manufacture of a successful TEVG4. The tissue engineering strategies that are currently
employed do not take advantage of this unique property to fabricate a blood vessel with a
vascular media that mimics that of native arteries30,53. However, it is thought that
manipulation of SMC phenotype at the appropriate maturation stage would be greatly
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beneficial in creating a blood vessel substitute that more closely resembles native arteries
in both organization and function63-64. For this reason, many investigators have studied
the various factors that are involved in phenotype modulation of VSMCs.

2.7.3 Factors Influencing VSMC Phenotype
A variety of factors have been shown to influence the behavior of VSMCs
including ECM components, growth factors, mechanical conditions and cell-cell
interactions. It has also been observed that the initial phenotype of SMCs affects their
subsequent response to the above mentioned stimuli65. Furthermore, it has been observed
that SMCs respond to some of these stimuli differently depending on whether they are
grown in a two-dimensional (2D) environment versus a 3D environment.

2.7.3.1 2D Substrates
SMCs in healthy arteries exist in the contractile phenotype, but when harvested
and grown on 2D culture dishes, they lose their contractility55,66. The loss of
myofilaments occurs in parallel with the development of a large Glogi complex, rough
endoplasmic reticulum and the secretion of ECM components. The expression of genes
that promote α-actin production are downregulated while those that code for growth
factors and their receptors are upregulated67. Collectively the introduction of SMCs into
an in vitro culture environment results in a shift from a contractile to a synthetic
phenotype over a period of days62.
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2.7.3.1.1 ECM & Growth Factors
As mentioned previously, SMCs in the native artery are embedded in a 3D matrix
of fibrous ECM molecules. These proteins participate in the transduction of signals
between the cell layers to regulate the adhesion, proliferation, migration and gene
expression of the SMCs by way of transmembrane receptors known as integrins15,68.
Thus, a host of in vitro studies have aimed to elucidate the specific effects of some of the
major ECM proteins. Several of these studies have shown that the presence of fibronectin
(FN) and type I collagen cause smooth muscle cells to shift to a synthetic phenotype4,69
while other proteins such as laminin (LN), heparin, elastin and type IV collagen have the
reverse effect, that is, they cause the cells to shift to a quiescent contractile phenotype4,70.
It has also been shown that growth factors like basic fibroblast growth factor (bFGF),
transforming growth factor-β1 (TGF- β1) and PDGF have regulatory effects on SMC
phenotype; the effects of the latter two being the most profound. TGF-β1 seems to
promote the migration of SMCs71-72 and increases ECM production73 but generally
suppresses proliferation4. However, as mentioned previously, the initial phenotype of
VSMCs can also dictate their response to certain stimuli. With respect to TFG-β1, rat
aortic SMCs grown in its presence become less proliferative when the initial phenotype is
a sub-confluent synthetic state. On the other hand, when confluent contractile cells are
cultured with TGF-β1 they respond with a transition to the synthetic state, simulating
hypertrophy61. Basic fibroblast growth factor bound to heparin sulfate proteoglycan has
been found to upregulate SMC proliferation56; while PDGF has more of a chemotactic
effect and indicates a shift to the synthetic phenotype by upregulating migration,

25
proliferation and ECM production74. LN, a basement membrane protein, has been shown
to retard the transformation of SMCs to a synthetic phenotype and maintains the
contractile phenotype for a long period of time upon initiation of in vitro culture
(immediately after harvest)75. A study conducted by Li et al.62 tested the effects of
Matrigel on smooth muscle cell phenotype. Matrigel is a solubilized basement membrane
matrix whose primary component is LN62. In the study, rat aortic SMCs were cultured on
plastic culture dishes (control) and on Matrigel coated culture dishes. The result was an
induction of the contractile morphology in cells grown on Matrigel compared to the
control group. Furthermore, cells grown on Matrigel had a low proliferative index,
increased expression of SM-α-actin and MHC, and finally, they exhibited increased
responsiveness to vasoconstrictors. Several studies have demonstrated a relationship
between serum content in growth media and VSMC phenotype76-82. In the absence of
serum or in very low serum concentrations it seems that SMCs shift from a synthetic to a
contractile phenotype. Although this practice may be of use in in vitro cell culture
studies, it cannot be adopted for tissue engineering procedures. Since the end goal is to
introduce the tissue engineered product into the human body, the abundance of serum
may undesirably trigger a pathological response (high synthetic activity). One of the
challenges in studying the effects is that these various locally produced growth factors
and matrix molecules tend to interact with each other to have a coordinated effect on the
smooth muscle and their effects tend to be interdependent4,74,83. It should also be noted
that these studies were conducted in a 2D environment and in serum-free conditions
which do not accurately emulate the in vivo environment.
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2.7.3.2 3D Substrates

2.7.3.2.1 ECM & Growth Factors
Several studies by Mequanint and co-workers have examined the effect of
scaffold surface modification with matrix proteins on VSMC behavior. Matrigel-coated
scaffolds, compared with bare scaffolds, promoted cell migration throughout the scaffold
depth and resulted in cells that were aligned in parallel to each other with rich F-actin
bundles, suggesting a differentiated phenotype84. A subsequent study comparing FNcoated scaffolds with Matrigel-coated and bare scaffolds revealed that FN promoted cell
infiltration to a greater extent than did Matrigel45. However, it was found that coating
scaffolds with matrix molecules had no effect on contractile marker expression. Another
study showed that polyurethane scaffolds conjugated with full length FN molecules
displayed favourable interactions with human coronary artery smooth muscle cells
(HCASMCs)85. Compared with the bare scaffold, the FN-functionalized scaffolds
promoted cell infiltration. FN, as discussed earlier, induces the synthetic phenotype in
SMCs. Therefore, fibronectin conjugated scaffolds have the potential to maintain SMCs
in a de-differentiated phenotype in order to produce the necessary cell numbers and ECM
components required of TEVGs. In a recent study, Baker and Southgate showed that LN
pre-coating of electrospun polystyrene scaffolds promotes cell differentiation to a
contractile phenotype86. As part of the same study, they found that the presence of serum
proteins in the culture medium prevented differentiation of the cells on bare scaffolds.
Upon removal of serum from the growth media, it was found that cells were no longer
able to adhere to the scaffold. Therefore, in tissue engineering of blood vessels, which
rely on the use of 3D scaffolds, serum withdrawal is not applicable.
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2.7.3.2.2 Scaffold Geometry
Another known regulator of SMC phenotype is the geometry of scaffolds used in
the engineering of vessels. Scaffolds aid in maintaining the spatial arrangement of cells,
provide mechanical strength and can also provide biological cues to guide the
development of the tissue. It has been shown that scaffold geometry can be used to
regulate various processes in SMCs, including: proliferation, migration, attachment to the
scaffold and other cells, differentiation and apoptosis43. Micropatterning is one such
method used to design the scaffold architecture in such a way as to precisely control the
behavior of cells. This is achieved through the addition of biological or chemical
molecules and topographical features onto the scaffold surface. Micropatterned surfaces
provide the advantage of replicating the dimensions and composition of the native in vivo
environment. Studies have shown that patterning of substrates has resulted in the
organization and alignment of SMCs into the contractile morphology4. For instance
Goessl et al.87 used lithography while Ra et al.88 patterned a substrate with collagen to
induce the spindle-like morphology. Problems associated with these studies include a
restriction or inhibition of cell proliferation resulting from the narrow microchannels, and
a large area of the substrate that is unavailable for cell growth. Furthermore, these studies
focused on cell alignment but failed to show a phenotype shift from synthetic to
contractile at the appropriate vessel maturation stage4.

2.7.3.2.3 Mechanical Stimulation
There are a variety of biomechanical stimuli in the native artery that make it an
incredibly dynamic environment. For example, longitudinal blood flow through the
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vessel exerts shear stress on the wall, while cyclic pressure variations due to blood flow
exert radial and longitudinal forces. Furthermore, the cells of the vasculature respond to
the constant stresses and strains and produce forces arising from vasoactivity. Of these, it
has been shown that cyclic stretching has the strongest correlation to SMC phenotype
generally resulting in increased ECM matrix secretion, cell proliferation, growth factor
production and contractile activity4. In 2D culture, experiments have shown a relationship
between cyclic strain and cell alignment. Mills et al.89 demonstrated the dependence of
SMC alignment on the amount of cyclic strain. High strain (7-24%) was shown to align
cells perpendicular to the strain gradient whereas low strains (0-7%) failed to organize
the randomly aligned cells. Various other studies have demonstrated a mitogenic effect of
mechanical strain and shear stress on SMC behavior through expression and activation of
PDGF90-92. Wilson et al.93 found that cyclic strain (60 cycles/ min) induced SMC
proliferation via production of PDGF. In the fabrication of vascular tissues, it has been
demonstrated that the mechanical properties of the engineered vessel as well as cellular
organization may be improved through dynamic mechanical conditioning. In a study by
Niklason et al.94, pulsatile flow (5% radial distension at 165 pulses per minute) induced
the desirable alignment of SMCs and production of large amounts of ECM proteins.
Eight weeks of exposure resulted in high values for burst strength. Mooney and Mikos
showed that cyclic strain improves histological organization and increased production of
elastin and collagen, both of which contributed to an improvement in mechanical
properties95. Seliktar et al.96 showed that engineered vessels consisting of rat aortic SMCs
exposed to 10% cyclic strain at 1 Hz for 8 days resulted in even distribution of and
circumferential orientation of cells as compared with static cultures. These responses are
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further dependant on the particular substrate on which the cells are grown. For example,
SMCs cultured (under cyclic mechanical strain) on FN or vitronectin were more
proliferative and secreted ECM molecules in comparison to cells cultured on collagen or
LN97. As promising as these results are, they also have drawbacks including long
conditioning periods which makes them impractical for clinical use and the lack of
formation of elastic laminae which contributes to irreversible creep in the graft vessel. In
addition, mechanical stimulation promotes the expression and activity of matrix
metalloproteinase-2 (responsible for the degradation of short collagens) which would
compromise the structure of the matrix. Furthermore, if mechanical conditioning is the
only stimuli used to maintain the SMC organization up until implantation of the vessel,
then risk of EC detachment poses another problem4.

2.7.3.3 The Role of ECs to Regulate VSMC Phenotype
ECs reside in close proximity to SMCs in the blood vessel and play an extensive
role in coordinating SMC behavior through the production of growth factors, stimulators
and inhibitors4. For instance, during blood vessel formation, ECs secrete PDGF and TGF
– β1 to recruit VSMCs or pericytes to the newly formed endothelial tube. In mature
arteries, the endothelium maintains homeostasis through the production of vasoactive
agents such as eicosanoids. In particular, prostacyclin has been shown to maintain SMCs
in a quiescent, contractile state in which they react to vasoactive stimuli but not to
mitogens98. Heparin is another endothelium derived molecule that maintains the vascular
media in a contractile phenotype while inhibiting proliferation and migration69. Much of
what we currently know about the interactions between ECs and SMCs has been derived
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from the study of vascular pathologies. In fact, atherosclerosis is initiated through a
mechanical disruption in the endothelial monolayer15. The disrupted endothelium is no
longer quiescent and becomes immunogenic. The subsequent cascade that is initiated
results in the migration and proliferation of SMCs to the intima. Therefore, a quiescent
endothelium is of critical importance in tissue engineered vascular grafts so as to not
provoke a pathological SMC phenotype upon implantation into the body. Various groups
have developed co-culture models to examine the interplay between these vascular cells.
These include: conditioned media, co-culture on opposite sides of a porous membrane,
microcarrier techniques, direct co-culture, and co-culture on a 3D collagen gel, which are
summarized below.

2.7.3.3.1 Conditioned Media
It has been reported that medium conditioned by ECs in various stages of growth
has an effect on smooth muscle phenotype, the results have however been mixed99-100.
Unlike proliferating ECs, cells that are organized in a quiescent confluent layer produce
heparin-like substances which have been shown to inhibit SMC proliferation99. A study
conducted by Campbell and Campbell concluded that conditioned media from quiescent
confluent endothelial cells shifted the SMCs into a contractile phenotype, whereas
conditioned media from proliferating ECs did not suppress SMC proliferation99. On the
other hand, Fillinger et al.100 found that conditioned media from quiescent confluent ECs
actually increased SMC proliferation. Other investigators observed no significant changes
in VSMC phenotype in culture with EC-conditioned media101-102. The results appear to be
mixed and the response of the SMCs appears to be dependent on culture duration103-107.
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2.7.3.3.2 Co-culture on Opposite Sides of a Membrane
Fillinger et al.108 constructed a co-culture model by seeding ECs and SMCs on
opposite sides of a 13µm thick PET membrane. They found that a confluent layer of ECs
increased SMC proliferation initially but after 4 days seemed to inhibit cell growth.
Additionally, the SMCs in co-culture displayed a spindle-like morphology. Van BuulWortelboer et al.107 used collagen gel to separate the two cell layers in culture and found
that in the presence of ECs, SMCs had lower proliferative activity. A study by Jacot and
Wong showed that endothelium, once injured and allowed to partially re-endothelialize,
induced a highly proliferative state in SMCs cultured on the opposite side of the same
membrane compared with uninjured endothelium in co-culture109. The regulation of SMC
behavior was attributed to PDGF-BB. Other studies110-111 altered serum concentration to
induce the synthetic or contractile phenotype in SMCs and then tested its effect on EC or
SMC gene expression or growth. Yet others112-113 used shear stress in a co-culture model
on opposite sides of a membrane to elucidate its combined effect (with SMCs) on EC
gene expression. In the native artery the internal elastic laminae, which separates the
intimal layer (containing ECs) from the medial layer (containing SMCs), has a thickness
ranging from 0.2 to 2 µm. Direct contact between the two cell layers is facilitated by
fenestrations in the lamina of 1.5 µm depth. Therefore, using porous membranes in in
vitro culture creates inaccurate models of native arterial structure. The large gap created
by these membranes (10 microns or greater) may restrict diffusion of EC-produced
molecules and gap junction formation between the ECs and SMCs114. Furthermore, the
use of a synthetic membrane is not applicable in the engineering of blood vessels115.
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2.7.3.3.3 Microcarrier Techniques
Microcarrier techniques rely on use of small spheres/ spheroids as the adherent
surface for anchorage-dependent cells. They are employed in order to achieve high yields
of cells as they provide a much larger surface area for monolayer formation compared
with standard culture dishes116. Korff et al.117 used a microcarrier system to construct cocultures of ECs and SMCs. They found that cells spontaneously organized into layers
resembling that of an artery wall. However, as in many other co-culture systems, they
only assessed the effect of SMCs on EC phenotype (proliferative vs. quiescent). Davies et
al.118 used microcarrier techniques to study the influence of ECs on LDL metabolism by
SMCs. These models, though important for investigating vascular cell interactions, are
not viable from a tissue engineering perspective. A tissue-engineered blood vessel must
have a tubular rather than spherical geometry in order to integrate into the surrounding
tissue and mimic the native vessel functions.

2.7.3.3.4 Direct Co-culture
Niwa et al.119 compared the uptake of LDL and acetylated LDL by ECs in
monoculture versus ECs in co-culture with SMCs. Co-culture increased the uptake of
LDL but had no effect on uptake of acetylated LDL. Additionally, shear flow had a more
pronounced effect on acetylated LDL uptake as compared with LDL uptake. In a study
more relevant to this project, Hirschi et al.120 cultured ECs with multipotent embryonic
10T1/2 cells (mural cell precursors). They demonstrated that co-culture induced a
morphological shift from polygonal to spindle-like shape. Additionally, several
contractile protein markers (MHC, smooth muscle 22α and calponin) were upregulated in
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co-culture compared with monocultured 10T1/2 cells. The differentiation process was
shown to be mediated by TGF-β. Similar results were observed in another study with ECs
and 10T1/1 cells121. It has also been shown that EC attachment onto SMCs can be
enhanced through the addition of ascorbic acid to increase collagen production by
SMCs122. A co-culture study by Chaterji et al.123 demonstrated the influence of EC
seeding density on SMC phenotype; culturing SMCs with near-confluent ECs
upregulated the expression of SM-α-actin and calponin. Expression levels were further
upregulated by pretreatment of SMCs with heparin and TGF-β. On the other hand, SMCs
cultured with sparse amounts of ECs displayed a hyperplastic phenotype. HeydarkhanHagvall et al.124 applied shear stress to a direct co-culture model to determine which
genes were differentially expressed. The major finding was that co-culture is a significant
factor in modulating EC responses to shear stress. A series of studies conducted by
Truskey and colleagues have used direct co-culture models to observe a variety of
behaviors. However, in all of these studies they induced a quiescent SMC phenotype
through serum withdrawal and examined primarily the behavior of ECs. These include:
the adhesiveness of ECs on SMCs115,125 and molecules mediating adhesion126, the
maintenance of a confluent endothelium under flow conditions, the effect of co-culture
on EC response to TNF-α127 and the expression of tissue factor by ECs in co-culture128. It
is important to note that all of these studies were performed on a 2D substrate. The major
drawbacks of using 2D co-culture models are that they ignore hemodynamic forces by
using static culture conditions or they ignore the effect of 3D geometry. A requirement of
tissue-engineered vessels is that they must be in the form of a 3D cellular construct. Thus,
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although data from 2D cultures can be used as a starting point, they may not truly reflect
cell behavior on 3D substrates.

2.7.3.3.5 Co-culture on 3D Collagen Gels
An investigation by Ziegler et al.129 involved the construction of a co-culture
system on 3D collagen gels. Porcine SMCs were embedded in a gel of collagen type 1
over which ECs were seeded. The ECs exhibited an elongated shape and random
orientation. Upon exposure to laminar shear stress the ECs aligned to the direction of
flow. Additionally, the collagen matrix was significant in maintaining the ECs in a
quiescent phenotype (as compared with plastic culture dishes that promoted
proliferation). Similarly, Imberti et al.130 constructed a similar model of SMCs imbedded
in a collagen matrix with an overlying layer of ECs. They also noticed that shear stress
induced alignment of ECs in the direction of flow, as well as a quiescent endothelium that
was attributed to the shear stress and collagen matrix. Neither of these studies, however,
observed interactions between ECs and SMCs.
Apart from the aforementioned studies, several investigators have carried out cocultures on 3D tubular scaffolds under dynamic growth conditions. Crouchley et al.131
used a tubular silicone scaffold for the sequential seeding of SMCs and ECs. Application
of mechanical stimulation resulted in the circumferential alignment of SMCs and was
accompanied by an increase in contractile protein expression. Cells were also able to
retain this phenotype after 24 hours of mechanical stimulation in co-culture. It should be
noted that serum-withdrawal was used to induce contractility in SMCs. Williams and
Wick sutured a biodegradable PGA nonwoven felt into a tubular construct that was
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subsequently seeded with SMCs and ECs132. Long-term culture versus short-term culture
in a bioreactor was compared. SMCs from long-term culture exhibited a more contractile
phenotype and increased levels of proliferation compared with cells from short-term
culture. ECM deposition had also decreased and was more uniform in long-term cultured
constructs. Pullens et al.133 conducted a study in which myofibroblasts and ECs were
cultured on 3D rectangular PGA and poly-4-hydroxybutyrate scaffolds for one or two
weeks to assess the impact of culture medium composition and ECs on ECM deposition.
Results indicated that EC culture medium and the presence of ECs in co-culture
decreased collagen content in the scaffolds.
In summary, these models have been important in elucidating the numerous
interactions between ECs and SMCs but have notable drawbacks. 2D models fail to take
into account the effect of geometry or hemodynamic forces observed in vivo.
Furthermore, the use of membrane separated co-culture system cannot be applied to
tissue engineering. Many of these studies also focused on the EC gene expression in coculture or the production of ECM proteins in 3D cultures. Recent reports have emerged
that document an induction of the contractile phenotype in VSMCs by VECs120,134-136.
The underlying mechanisms are only now beginning to emerge from 2D co-culture and
gene knockout experiments137-139. Mechanisms that have been shown to play a role in this
modulation are the PI3-kinase/Akt pathway140, the protein kinase A pathway via
prostacyclin receptor141 and the Notch signaling pathway via Jagged1 ligand101,138,142-146.
Due to the relevance of Notch signaling to this thesis, a brief review is presented.
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The Notch signaling pathway is an evolutionarily conserved pathway that dictates
cell fate through local cell-cell interactions. These interactions are critical in the control
of cell proliferation, differentiation and apoptosis143. Components of the Notch signaling
pathway include the Notch family of transmembrane receptors (Notch1 to 4), the Delta,
Serrate/Jagged, Lag-2 family of transmembrane ligands (Delta like1, 3 and 4 and Jagged1
and 2), and the various effectors from the hairy enhancer of split (HES) and HES-related
repressor protein (HERP) family143, 144. The distribution of Notch signaling components
within vertebrates varies significantly throughout tissues and during development.
However, data suggests that several of these are confined to the vasculature including the
ligands Delta like4, Jagged1 and 2, the receptors Notch1, 3 and 4 and the effectors
HERP1, 2 and 3143. Interaction of the extracellular domain of the Notch receptors with
their ligands on neighbouring cells leads to proteolytic cleavage of the receptor thereby
freeing the Notch intracellular domain (ICD). Once the ICD translocates to the nucleus, it
associates with C-promoter-binding factor-1 to form a multiprotein complex that initiates
DNA transcription of the Notch effector genes (HES and HERP)

151

. Notch signaling

plays an important role in vascular development and in the pathogenesis of vascular
diseases. In VSMCs in particular, Notch activity regulates cell differentiation,
proliferation, migration and survival144,

152-153

. Notch3 is the primary receptor that is

expressed by VSMCs and its ligand Jagged1 is predominantly expressed by VECs143, 101,
154-155

. Impaired activity between Notch3 and Jagged1 has been shown to induce

pathologies such as cerebral autosomal-dominant arteriopathy with subcortical infarcts
and leukoencephalopathy (CADASIL) and Alagille syndrome in humans143. Further data
supporting the importance of Notch signaling in vasculature comes from experiments
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involving the knockout of Jagged1 in mice which resulted in the absence of smooth
muscle gene expression giving rise to an embryonic lethal phenotype156-157. Based on this
evidence, the role of VEC-induced VSMC phenotype modulation via the Notch signaling
pathway will be a focus of this study.

2.8 Study Rationale and Objectives
The shortcomings of CAD interventions have actuated a venture into the
emerging field of vascular tissue engineering. More specifically, investigations
undertaken by our laboratory have focused on the development of novel materials for use
as vascular scaffolds and more recently on the interactions between VSMCs and 3D
substrates. The failure of small-diameter vascular substitutes consisting of only a subset
of the arterial components has spurred investigations of issues like VSMC phenotype
regulation. It has been widely acknowledged that strategic control of VSMC phenotype at
the appropriate tissue maturation stage would be greatly beneficial in creating a
physiologically compliant vascular graft. Studies have shown that VECs play a key role
in the modulation of VSMC phenotype. Investigation of VEC-induced VSMC phenotype
modulation is therefore beneficial for the fabrication of TEVGs. In view of this, the
purpose of this study was to characterize the interactions between HCASMCs and human
coronary artery endothelial cells (HCAECs) on a 3D scaffold.

In particular, we have chosen to study primary human coronary artery vascular
smooth muscle and endothelial cells. Given that there are major functional differences
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between vascular cells from different vascular beds147-148 and from different species149,
the use of adult human coronary artery vascular cells best emulates the expected behavior
of autologous cells150.

We hypothesize that HCAECs will modulate the phenotype of HCASMCs from a
synthetic to a contractile phenotype via the Notch signaling pathway when cultured on a
3D substrate of PCU. To test this, we have set out the following specific objectives.

i) Co-culture HCASMCs and HCAECs on porous 3D PCU scaffolds in distinct
layers mimicking the native artery wall.
ii) Determine if the presence of HCAECs has an effect on HCASMC phenotype
through the examination of differentiation markers.
iii) Elucidate whether any observed modulation of phenotype is mediated by Notch 3Jagged1 interactions.
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Chapter 3 - Materials and Methods

3.1 Materials
A poly(carbonate urethane) (PCU; Bionate® 55D) was used to fabricate the 3D
scaffolds in this study and was supplied by Polymer Technology Group (Berkeley, CA).
Ammonium chloride (NH4Cl) supplied by Caledon Laboratories Ltd (Georgetown, ON,
Canada) was used to create the porous structure of the scaffolds. Dimethylformamide
(DMF) from Caledon Laboratories was used as a solvent for PCU. FN and Matrigel were
supplied by Santa Cruz Biotechnology (Santa Cruz, CA) and Becton Dickenson (Franklin
Lakes, NJ) respectively. Hank’s balanced salt solution (HBSS), used for solubilizing FN
was supplied by Invitrogen (Burlington, ON, Canada). Penicillin G and streptomycin
sulfate were purchased from Invitrogen. Cell culture studies were conducted utilizing
primary HCASMCs and primary HCAECs in smooth muscle growth media (SmGM®-2
BulletKit) (SmGM) and endothelial cell growth media (EGM®-2 Bullet Kit) (EGM),
respectively, all of which was supplied by Lonza Walkersville Inc. (Walkersville, MD).
For cell fixation purposes paraformaldehyde was purchased from EMD Chemicals
(Gibbstown, NJ). Saponin, purchased from Sigma Chemical Co. (Germany), was used for
cell permeabilization in some experiments. For immunostaining: Alexa Fluor® 488
Phalloidin and CellTracker™ Green CMFDA (5-chloromethylfluorescein diacetate)
(CTG) were purchased from Invitrogen (Eugene, OR), anti-VE-cadherin antibody was
purchased from Santa Cruz Biotechnology and lastly Hoechst 33342 was purchased from
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Sigma-Aldrich (Oakville, ON, Canada). Bovine serum albumin (BSA) was supplied by
Sigma-Aldrich and Vectashield mounting medium was supplied by Vector Laboratories
(Burlington, ON, Canada). Anti-PECAM-conjugated Dynabeads (Invitrogen Dynal AS,
Oslo, Norway) were employed for cell separation in co-culture. Control and Jagged1
siRNA ON-TARGETplus SMARTpool duplexes from Dharmacon were used for gene
knockdown studies. siRNA reagents Opti-MEM reduced serum medium and
™

Lipofectamine RNAiMAX Reagent were purchased from Invitrogen (Grand Island,
NY) and Invitrogen (Carlsbad, CA) respectively. Antibodies for use in Western blot
(anti-SM α-actin, anti-calponin, anti-Notch 3, anti-Jagged1) were purchased from Santa
Cruz Biotechnology with the exception of GAPDH which was purchased from Millipore
(Temecula, CA). Protein concentrations were measured using 660 nm Protein Assay
supplied

by

Thermo

Scientific

(Ottawa,

Canada).

SuperSignal®

West

Pico

Chemiluminescent Substrate was supplied by Thermo Scientific (Rockford, IL). Protein
G Dynabeads and recombinant human Jagged1/Fc chimera protein (1277-JG) were
supplied by Invitrogen (Burlington, ON, Canada) and R&D Systems (Minneapolis, MN)
respectively. RNA analysis of HCASMCs was achieved using TRIzol® Reagent and
SuperScript™ from Invitrogen and a Chromo4 Real-time Thermal Cycler, iQ™ SYBR®
Green Supermix and Gene Expression Macro analysis software from Bio-Rad
(Mississauga, ON, Canada).
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3.2 Methods
3.2.1 Scaffold Fabrication
PCU scaffolds were fabricated using a solvent casting and particulate leaching
(SCPL) method as established in our laboratory1. In brief, NH4Cl porogen particles were
ground to the diameter range of 180-210 µm using a mortar and pestle. Particles were
then passed through graded sieves and those falling into the desired range of 180-212µm
were collected. The collected particles were re-sieved to ensure they fell into narrow size
distributions. Using the set-up shown below (Figure 3.1) the porogen was poured into the
glass mold and compressed using air pressure to achieve high pore density and
uniformity. A polymer solution consisting of 20% (w/v) PCU in DMF was added to the
steel chamber and infiltration through the porogen bed was aided by the application of a
pressure differential. The scaffold was then left for a period of three days to evaporate the
solvent. The NH4Cl particles were then leached out using water (a non-solvent for PCU)
after which the scaffold was dried (Figure 3.1B) and sectioned into 0.5mm thick discs
(Figure 3.1C) prior to use in cell culture studies.
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Figure 3. 1: Scaffold fabrication apparatus. Apparatus used for fabricating PCU scaffolds
using SCLP technique (A); Resulting scaffold after porogen leaching and drying (B); Scaffold
discs used for cell culture (C).

3.2.2 Scaffold Characterization
To verify uniform scaffold structure and pore size, the fabricated scaffolds were
imaged using a scanning electron microscope (SEM) (S-2600N, Hitachi, Japan).
Scaffolds were sectioned into cylindrical disks of 5.5 mm diameter and 0.5 mm thickness
using a rotary blade cutter, then sputter coated with gold and imaged.
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3.2.3 Scaffold Preparation for Cell Culture
Cylindrical scaffold disks were affixed to the bottom of a 96-well culture plate
using silicone grease. A solution of FN diluted in HBSS was adsorbed onto the scaffold
surfaces overnight in the dark at a density of 5µg/scaffold. Scaffolds were kept hydrated
in HBSS prior to cell seeding.

3.2.4 Cell Culture
Primary HCASMCs and primary HCAECs were cultured in SmGM and EGM
respectively. Both media were supplemented with 100 units/ml penicillin G and 100
µg/ml streptomycin sulfate. Cell cultures were maintained in a humidified incubator at
5% CO2 and 37°C and were used between passages 5 and 9.

3.2.5 2D Monoculture
Experiments that were performed for optimizing FN concentration and media
composition were carried out on glass coverslips. FN was diluted in distilled water to
desired concentrations of 10 µg/cm2, 5 µg/cm2, and 2 µg/cm2 and adsorbed onto
coverslips for 1 hour. HCASMCs were seeded onto coverslips of different FN
concentrations at a density of 25,000 cells/coverslip and cultured in SmGM for 2, 4 or 7
days. For growth media experiments, HCASMCs and HCAECs were seeded at densities
of 25,000 cells/coverslip and 20,000 cells/coverslip, respectively, onto substrates of 5µg
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FN/cm2. HCASMCs were cultured for 4 days while HCAECs were cultured for 2 days in
media compositions of: pure EGM, pure SmGM, or 1 part EGM and 1 part SmGM.

3.2.6 2D Culture for RT-PCR
For RT-PCR work, cultures were carried out on 24-well treated polystyrene tissue
culture dishes. Culture wells were first coated with 5 µg/cm2 of FN diluted in HBSS. For
monocultures, HCASMCs were seeded at a density of 1.7x104 cells/well and cultured for
48 hours with 5 µg/ml of Jagged1 protein or 10 µL/well of Jagged1/IgG-immobilized
Dynabeads. For co-cultures, HCASMCs were seeded at a density of 1.7x104 cells/well
and cultured for 48 hours in SmGM. HCAECs were then seeded at a density of 1.7x104
cells/well over the HCASMC layer and cultured for an additional 48 hours in co-culture
media. Co-culture media consisted of SmGM and EGM at a 1:1 ratio.

3.2.7 3D Co-culture of HCASMCs and HCAECs on PCU scaffolds
HCASMCs were seeded onto the scaffold discs at varying initial densities
depending on the experiment and allowed sufficient time for attachment in a 37°C, 5%
CO2 incubator. After attachment, scaffolds were transferred to a 24-well culture plate
with 2 ml of SmGM and cultured at 37°C, 5% CO2 for 48 hours. Matrigel was solubilized
in serum-free growth media and added over the HCASMC layer (for co-cultures) or over
bare scaffolds (for HCAEC monocultures) to promote HCAEC attachment. The Matrigel
solution was adsorbed for one hour at 37°C just prior to HCAEC seeding in a 96-well
plate. HCAECs were seeded onto scaffolds containing HCASMCs or onto Matrigel-
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adsorbed scaffolds and incubated at 37°C and 5% CO2 for three hours to allow cell
attachment. Scaffolds were then transferred back to a 24-well dish with 2 ml of growth
media (EGM for EC monocultures or SmGM and EGM at a 1:1 ratio for co-cultures) and
cultured for an additional 48 hours.

3.2.8 Immunofluorescence Staining and Fluorescence Microscopy of 2D
cultures
Cell cultures from FN concentration and growth media experiments were stained
for F-actin filaments prior to image analysis. Cells were fixed to their coverslips for 10
minutes using freshly prepared 2% paraformaldehyde and washed 3 times with 1x
phosphate buffered saline (PBS). A solution of 0.1% Saponin was applied for 5 minutes
to permeabilize the cell membranes. Following 3 washes in 1 x PBS, samples were
incubated in Alexa Fluor® 488 Phalloidin diluted (1:50) in 1% BSA/PBS for 1 hour.
Finally, cells were washed 3 times using 1 x PBS on the first and third washes and 1 x
Hoechst 33342 (10ug/ml) on the second wash. Coverslips were mounted onto microscope
slides using Vectashield as a mounting medium and were sealed using nail enamel.
Fluorescence images were captured using a Leica CTR Mic fluorescence microscope (Hg
bulb) and Openlab software.
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3.2.9 Immunofluorescence Staining and Laser Scanning Confocal
Microscopy of 3D cultures
Post-culture immunostaining was performed to allow for visualization of cell
organization and morphology on 3D scaffolds. SMCs were live-stained using CTG at a
concentration of 10 µM in serum-free media for 45 minutes. Following two 30-minute
incubations in SmGM (to rinse out the unincorporated dye and by-products), a thin
coating of Matrigel was applied and HCAECs were seeded and cultured for 48 hours as
described above. Cells were fixed using a 4% solution of paraformaldehyde,
permeabilized in 0.5 % Triton X-100 and washed three times with 1 x PBS. Long-term
SMC monocultures were stained as described for 2D cultures above. Co-cultured cellscaffold constructs and HCAEC-scaffold constructs were incubated in 1% BSA/PBS with
VE-cadherin antibody (1:50 dilution) for one hour followed by three washes in 1 x PBS.
Scaffolds were then incubated in Alexa Fluor® 568-conjugated secondary antibody for
one hour, washed three times with 1 x PBS and incubated with Hoechst 33342 (10 µg/ml)
for 5 minutes to label the nuclei of all cells. Samples were mounted on glass microscope
slides in a mounting medium composed of glycerol and water (glycerol:water, 9:1v/v).
Spacers were used to construct elevated wells in which the scaffolds were contained;
wells were sealed using coverslips and nail enamel. A Zeiss LSM 410 confocal
microscope (Carl Zeiss, Germany) equipped with argon/ neon and UV lasers was used for
imaging the samples. 3D image stacks were created by taking serial optical slices at
regular increments through the samples.
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3.2.10 Separation of HCAEC from Co-culture
In order to examine the individual contributions of each cell type toward protein
expression in co-culture, anti-PECAM conjugated Dynabeads were employed to separate
the HCAECs from the HCASMCs. First, cells were recovered from scaffolds or culture
plates by incubating in a 0.25% Trypsin/EDTA solution at 37°C for 5 minutes. This
method has proved effective in the past for cell recovery from PCU scaffolds2. Scaffolds
or culture plates were then rinsed several times with a low serum content-buffer (5% fetal
bovine serum in 1 x PBS) to neutralize the trypsin activity. The trypsinized cell
suspension was centrifuged for 5 minutes at 21°C and the pellet was re-suspended in
0.1% BSA/PBS. Washed Dynabeads (25 µL/108 HCAECs) were mixed with the cell
suspension and rotated at 4°C for 20 minutes to facilitate attachment to HCAECs.
Following incubation, samples were placed in a magnet to separate the bead-bound
HCAECs from the supernatant (HCASMC). The supernatant was collected and the beadbound cells were rinsed and magnetized three more times to increase the separation
efficiency. For protein extraction, the bead-bound HCAECs and supernatant
(HCASMCs) were immersed in sodium dodecyl sulfate (SDS) sample buffer after
centrifugation. For RNA extraction, the bead-bound HCAECs and the supernatant
(HCASMCs) were centrifuged and resuspended in TRIzol® Reagent.

3.2.11 Jagged1/Fc Protein Immobilization to Dynabeads
Protein G Dynabeads were washed 3 times with PBS (pH 7.4, 0.02% Tween) and
mixed with 5 µg of human Jagged1/Fc chimera protein in the original bead volume. The
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mixture was incubated for 10 min at room temperature on a rotating device and the
Jagged1-immobilized beads were washed 3 times with PBS. As a control of Jagged1/Fc
chimeric protein, beads were incubated with human IgG solution (5 µg/ml) at the same
conditions with those used for Jagged1 binding. This control addresses the effect of the
Fc fragment of Jagged1 for any possible non-specific effects of the Fc protein. Beads
were added to cell cultures at a concentration of 10 µL/well.

3.2.12 Transfection of HCAEC with Jagged1 siRNA
Prior to transfection, HCAECs were passaged in antibiotics-free growth media
such that they would be at 50% confluence at the time of transfection. 200 pmol of
control siRNA or Jagged1 siRNA was diluted in 1 ml of Opti-MEM reduced serum
medium. Each of these solutions was then mixed with another 1 ml of Opti-MEM
™

reduced serum medium containing 20 µL of Lipofectamine RNAiMAX. Solutions were
incubated at room temperature for 20 minutes before being added to a culture dish of
50% confluent HCAECs. Following 24 hours in a 37°C, 5% CO2 incubator, cells were
trypsinized and seeded onto either bare scaffolds or scaffolds containing HCASMCs.
Following the 48 hour co-culture period, cells were harvested and lysed to test the
transfection efficiency and protein expression levels.
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3.2.13 RNA Isolation and Quantitative Real-time PCR Analysis
Real-time polymerase chain reaction (PCR) combined with reverse transcription
was used to quantify messenger RNA of Notch3, SM-α-actin and calponin in HCASMCs
grown on 2D surfaces. Total RNA from HCASMCs was isolated using TRIzol® Reagent
following the manufacturer’s protocol. Complementary DNA was synthesized using 1 µg
of total RNA primed with oligo(dT)12-18 as described in SuperScript™. Conventional
reverse transcription PCR was used to test primer specificity by running PCR for 40
cycles at 95°C for 20 s and 52°C for 1 min. Quantitative real-time PCR was conducted in
10 µL reaction volumes, using a Chromo4 Real-time Thermal Cycler and gene
expression of human Notch3, SM-α-actin, calponin and glyceraldehyde3-phosphate
dehydrogenase (GAPDH) were then determined with iQ™ SYBR® Green Supermix
according to the recommended protocol of the manufacturer. Notch3 forward primer, 5'CCT AGA CCT GGT GGA CAA G -3', and reverse primer, 5'-ACA CAG TCG TAG
CGG TTG -3'; SM-α-actin forward primer, 5'-CAA GTG ATC ACC ATC GGA AAT G3', and reverse primer, 5'-GAC TCC ATC CCG ATG AAG GA-3'; calponin forward
primer, 5'-TGA AGC CCC ACG ACA TTT TT-3', and reverse primer, 5'-GGG TGG
ACT GCA CCT GTG TA-3'; GAPDH forward primer, GGT GGT CTC CTC TGA CTT
CAA CA, and reverse primer, GTT GCT GTA GCC AAA TTC GTT GT, were used3.
Cycling parameters were optimized as follows: denaturation 95°C (10 s), gradient
annealing 50°C/65°C (10 s), extension 72°C (30 s), and running for 39 cycles.Notch3,
SM-α-actin and calponin gene expressions in HCASMCs were normalized to GAPDH
with at least three repeats per experimental group and expressed as relative ratios using
the Gene Expression Macro analysis software.
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3.2.14 Protein Extraction and Western Blot
Expression levels of Jagged1, Notch3, SM-α-actin and calponin in 3D cultures
were evaluated using Western blotting. Scaffolds from different culture conditions were
incubated in 0.25% Trypsin/EDTA for 5 minutes at 37oC. The trypsin solution was
pipetted repeatedly into the scaffolds to recover cells after which the cells were
centrifuged and collected. Cells from co-culture were separated using anti-PECAM
conjugated Dynabeads (as described above) while cells from monocultures were
immediately immersed in 100 µL of SDS sample buffer containing 5% (v/v) βmercaptoethanol. Lysates were micro-centrifuged and the protein concentrations were
determined using 660 nm Protein Assay. 20 µg/well of protein was loaded and separated
by 10% SDS-polyacrylamide gel electrophoresis for 50 minutes then subsequently
transferred overnight at 4°C onto a nitrocellulose membrane while submerged in a Trisglycine buffer. Ponceau S stain was used to verify proper transfer. Membranes were then
blocked with 5% non-fat dry milk in 1 x PBS for one hour and incubated in primary
antibodies (diluted in 5% non-fat dry milk in 1 x PBS): anti-SM α-actin (1:1000 dilution),
anti-calponin (1:1000 dilution), anti-Jagged1 (1:200 dilution), anti-Notch3 (1:200
dilution) and anti-GAPDH (1:2000 dilution) for 2 hours. After incubation with HRPconjugated secondary antibodies for 45 minutes, membranes were incubated for 5
minutes in SuperSignal®West Pico Chemiluminescent substrate. Bio-Rad’s ChemiDoc™
XRS+ System (Mississauga, ON, Canada) was used to image the membranes and blots
were quantified using Image Lab™ software.
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3.2.15 Statistical Analysis
Quantified data for RNA and protein expression levels were plotted and analyzed
using GraphPad Prism 5. Values were normalized against GAPDH and graphs were
constructed using data from at least three independent experiments. Quantified data are
presented as mean ± standard deviation and were statistically analyzed by one-way
ANOVA followed by Tukey’s post hoc test to compare differences between two groups.
Values of p < 0.05 were considered to be statistically significant.
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Chapter 4 – Results and Discussion
4.1 Gene Expression Levels in HCASMCs and HCAECs from
2D Co-culture
One of the main objectives of this study was to examine possible phenotype
changes that HCASMCs may undergo in the presence of HCAECs. Before introducing
HCAECs into co-culture studies with HCASMCs, we conducted a series of experiments
to determine if an EC secreted molecule, Jagged1, exogenously added to HCASMC
cultures could affect the regulation of gene expression leading to phenotype modulation.
To this end, a series of experiments that analyzed gene expression in HCASMCs cultured
in the presence of soluble Jagged1, immobilized Jagged 1 and EC-surface expressed
Jagged1 were compared.
Although it has been detected in arterial SMCs, Jagged1 is a transmembrane
protein that is predominantly expressed by VECs1-4 while the Notch3 receptor is a
membrane-bound protein that is expressed in VSMCs. Binding of the Notch receptor
with its ligand (Jagged1) results in activation of the Notch signaling pathway and
ultimately prompts differentiation in VSMCs5. A host of in vivo and in vitro studies have
demonstrated a vital function of Jagged1 in regulating SMC differentiation2,5-9. These
studies formed the basis for our examination of gene expression levels of Notch3 and
various differentiation markers in HCASMCs and HCAECs.
Several reports have demonstrated the ability of soluble Jagged1 to induce
differentiation of keratinocytes10-11, mesenchymal stem cells into cadriomyocytes12 and
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cochlea progenitor cells into primary sensory cells13. Other studies have shown
contrasting findings in which Notch ligands in immobilized form is a requirement for
inducing differentiation14-17. Alternatively, considering that the Jagged1 ligand is an EC
transmembrane protein, signaling is generally assumed to be mediated by cell-cell
contact18; hence VSMC phenotype modulation may be contact-dependant19-20. If soluble
Jagged1 was able to induce contractility in HCASMCs then it could be delivered to cells
via culture media during vascular tissue engineering. If, on the other hand, Jagged1immobilized beads produced a significant enhancement of Notch3 and SMC contractile
gene expression, Jagged1-functionalized scaffolds could be designed. Given the
complexity of 3D culture systems a 2D model was chosen to simplify and ensure delivery
of these molecules to cultured cells.

4.1.1 Effects of Soluble and Immobilized Jagged1 on HCASMC Gene
Expression
In the first of these experiments, HCASMCs were cultured on a 2D substrate of
tissue culture–treated polystyrene for 48 hours in media containing 5 µg/ml soluble
Jagged1. This was followed by RNA extraction for RT-PCR as described in Chapter 3.
The role of soluble Jagged1 in HCASMC phenotype modulation was assessed through
examination of Notch3, SM-α-actin and calponin gene expression levels. SM-α-actin and
calponin are early-to-mid stage SMC differentiation markers that are known to be
upregulated in the contractile phenotype21-22. SM-α-actin was also chosen because it is a
direct target of Notch activity23-24. Results from Figure 4.1A-C indicate that soluble
Jagged1 was unable to produce any significant changes in terms of HCASMC gene
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expression compared with the controls in which HCASMCs were cultured in pure SmGM
as well as a second condition consisting of HCASMCs cultured in IgG-supplemented
SmGM (p>0.05). The IgG control accounts for any non-specific effects of the Fcfragment found on the Jagged1 protein. These results suggest that Jagged1 protein in and
of itself is not sufficient in promoting Notch signaling activity.

Figure 4.1: Effect of Soluble Jagged1 and Immobilized Jagged1 on Notch3 and HCASMC
Gene Expression. HCASMCs were culture for 48 hours with soluble Jagged1 (A-C) or Jagged1immobilized protein G beads. Gene expression levels of Notch3 (A, D), SM-α-actin (B, E) and
Calponin (C, F) are shown. The asterisks indicate statistically significant difference (p < 0.05). In
Figs A-C, control refers to HCASMCs cultures in pure SmGM.

Since soluble Jagged1 did not affect HCASMC gene expression, the role of
Jagged1 immobilized to the surface of protein G beads could influence Notch and SMC
contractile gene expression. The reasoning behind this was that the bead surface could
potentially mimic a signaling cell surface by presenting the Jagged1 ligand to adjacent
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HCASMCs. Furthermore, it would provide insight into biomaterial-mediated Notch3
signaling. Results from Figure 4.1D-F show that although Jagged-immobilized beads
were able to significantly upregulate Notch3 gene expression in HCASMCs (p<0.05), a
corresponding increase in contractile gene expression was not detected (p>0.05) which is
presumably due to an already high basal level of contractile gene expression. This
suggests that other biochemical or structural cues  that are not offered by the Jagged1immobilized beads  may be necessary to activate the signaling cascade that results in
HCASMC differentiation. Alternatively, the upregulation of the Notch3 gene may not
translate into Notch3 protein expression which may be elementary in inducing the
contractile phenotype in HCASMCs. Nonetheless, these results indicate the need for a
model that recapitulates the interactions between Jagged1 and Notch3 in vivo.
Complementary experiments that support these results are shown in our previous
publication25. The general finding was that Jagged 1 in soluble or immobilized form is
not capable of producing an increase in HCASMC contractile protein expression.

4.1.2 Effect of HCAEC Jagged1 Knockdown on HCASMC Gene
Expression
The next step to investigate Notch-induced gene expression in 2D cultures was to
examine the effect of EC-bound Jagged1 on Notch activity. In order to do this, a direct
co-culture model was chosen to allow for heterotypic cell-cell contact. This type of
interaction has been shown to be a requirement for Notch3 activation and subsequent
SMC contractile marker expression2. Jagged1 was knocked down in HCAECs using
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siRNA and was followed by 48hours of co-culture of HCAECs with HCASMCs. Cells
were separated using PECAM-coated magnetic beads prior to RNA extraction as
described in Chapter 3. Results are shown in Figure 4.2 below.

Figure 4.2: Effect of siRNA knockdown of Jagged1 on gene expression levels in co-culture.
Expression levels of Notch3 (A) and SM α-actin (B) in HCASMCs and HCAECs co-cultured for
48 hours and subsequently separated using PECAM-conjugated magnetic beads. Asterisks
indicate statistically significant data (p<0.05).

As is shown in Figure 4.2, siRNA knock down of Jagged1 in HCAECs significantly
downregulated the expression of Notch3 in HCASMCs in co-culture (p<0.05). This was
further translated into a significantly lower expression of SM-α-actin in HCASMCs
suggesting a direct link between HCAEC-bound Jagged1 and HCASMC differentiation
(p<0.05). Unlike immobilized Jagged1, which was able to upregulate the expression of
Notch3 in HCASMCs but failed to upregulate contractile marker expression, HCAECbound Jagged1 appears to have a direct effect on the expression of Notch3 and SM-αactin in HCASMCs. Complimentary experiments were performed to examine the effects
of HCAEC-bound Jagged1 on HCASMC protein expression. The results, shown in our
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recent publication25, were in agreement with the gene expression data; that is, direct
heterocellular cell-cell contact is necessary for HCASMC differentiation via Notch3
signaling. This in turn validates the need for a direct co-culture system in 3D for studying
the controlled modulation of HCASMC phenotype. Based on these exploratory
experiments, a 3D culture approach for SMCs phenotype modulation is now needed.

4.2 Scaffold Characterization
Scaffolds were fabricated using a SCPL method by the application of pressure to
force polymer solution through a tightly packed porogen bed. SCPL was used because it
allows for easy control of pore size and porosity26. The polymer and porogen of choice
were PCU and NH4CL, respectively. Polyurethanes are among the various natural and
synthetic polymers that are commonly used for tissue engineering applications. With
regard to vascular tissue engineering, degradable polymers are generally favoured as
scaffolding materials; however, traditional polyesters such as PLLA, PGA and their
copolymers, although promising, tend to form acidic degradation products in vivo that
can impact VSMC phenotype27 and cause inflammation28. Protein hydrogels composed of
natural polymers such as collagen type I29, fibrin30-31 and elastin32 have displayed a high
degree of biocompatibility but generally lack the necessary mechanical properties that are
required of a blood vessel substitute33 even after weeks of in vitro maturation34.
Furthermore, biodegradable scaffolds may prematurely degrade in vivo before sufficient
graft remodeling has taken place, leading to weak neotissue35-36. In this respect, biostable
scaffolds are advantageous since they have the capacity to carry mechanical loads
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enabling the graft to function immediately upon implantation  a requirement for
engineered vascular tissues. Biostable polyurethane elastomers have been extensively
used for biomedical and vascular applications due to their acceptable biocompatibility
and excellent mechanical characteristics37-41. PCU was utilized in this study based on (1)
its proven elasticity42-44, (2) the fact that there are no degradation products that can
adversely modulate VSMC behavior and interfere with evaluation of VSMC phenotype27,
(3) the ability to recover cells for biochemical analysis without contamination by scaffold
fragments and (4) its capacity for supporting the growth of vascular cells38,45-46. Before
commencing cell culture studies it was important to first verify the structure of the
scaffolds in use since scaffold geometry and pore structure may significantly impact cell
infiltration and communication46. The structure of the fabricated PCU scaffolds, show in
Figure 4.3, was highly porous, uniform and interconnected.

Figure 4.3: Scanning electron micrographs of porous PCU scaffolds. Scanning electron
micrographs of scaffolds fabricated from PCU with porogens ranging from 180-212μm in
diameter; A) Arrow indicates scaffold edge, pores are highlighted in yellow; B) Arrows indicate
interconnecting pores. Scale bar, 250µm.
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Since the pores are defined by the x, y and z planes, it was difficult to take an
accurate measurement of pore size based solely on qualitative analysis. However,
because PCU scaffolds fabricated from the SCPL method were extensively studied by
Mequanint and co-workers46-47 it was not necessary to analyze the pores in depth. The
pores outlined in Figure 4.3A gives values ranging from 142µm to 254µm for pore
diameter. There are several possible reasons for the variance in pore size. Firstly, the
isotropy of the pore dimensions can be attributed to the irregular shape of the ground
NH4Cl particles46. Particles having a narrow diameter in one plane but a large diameter in
another plane may easily become trapped in the sieve or pass right through depending on
the particle’s orientation during sieving. As a result, some pore sizes fall outside the
expected range of 180-212µm. Secondly, evaporation of the DMF solvent likely results
in volume reduction of the scaffold struts; consequently, the pore size increases. The
reasoning behind the choice of porogen size was two-fold. First, it has been identified
that the optimal pore size range for vascular tissue engineering applications is 150300µm48. Second, a large surface area to volume ratio is necessary for the recruitment
and maintenance of a dense cell population38,49 and a reduction in pore size results in a
higher surface area to volume ratio45. Thus, particles were chosen from the lower end of
the range to meet both of the above criteria. Although porosity calculations were not
performed in this study, previous work in our laboratory has shown that PCU scaffolds
fabricated using NH4Cl and SCPL result in structures with 84% porosity  which falls
into the optimal range of 80-90%38. In comparison to those scaffolds, those used in this
study have thinner struts and so the porosity value may actually be higher. Scaffold
architecture has been identified as an important factor in facilitating cell-cell and cell-
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matrix communication and in providing the necessary mechanical strength. High porosity
and large interconnected pores promote tissue ingrowth, vascularization, interstitial fluid
flow and diffusion of nutrients and waste50-52. Furthermore, cell migration is discouraged
if there are no interconnecting pores53 and a lack of structural uniformity produces
inferior mechanical properties54. Since the porogen particles were ground and sieved into
a narrow size range, a relatively uniform pore size could be achieved. Microporosity is
another critical property to be considered. A delicate balance must be struck to limit the
microporosity to a reasonable value in order to retain the mechanical integrity of the
scaffold. Micropores are essential in allowing capillary ingrowth during in vivo
remodeling54. On the other hand, an overabundance of micropores  specifically those
that do not link the macrovoids  can detract from the mechanical strength of the
scaffold. This is crucial in the case of vascular grafts since compliance and structural
integrity are imperative48. SEM images (Figure 4.3) of scaffolds fabricated for this study
show the presence of micropores on the order of 16 µm or less. These pores should
significantly improve the formation of a 3D tissue by facilitating cell-cell
communication, mass transfer and capillary infiltration55. Studies previously conducted
by our group demonstrated that PCU scaffolds fabricated using NH4Cl and employing the
SCPL method have mechanical properties comparable to that of native blood vessels47.
Therefore, the degree of microporosity seen here may not adversely affect the strength of
the scaffold. The relative rate at which solvent is exchanged for nonsolvent during
scaffold fabrication determines the extent of micropore formation48; so if required,
microporosity can be controlled through careful selection of solvent/ nonsolvent pairs. As
demonstrated by these findings, scaffolds constructed for the current study exhibit the
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qualities that are essential for vascular tissue engineering applications: they are
structurally uniform, highly porous and highly interconnected.

4.3 Optimizing Conditions for Co-Culture

4.3.1 Effect of Varying FN Concentration on HCASMC Attachment and
Proliferation
Cell adhesion plays a crucial role in guiding cell fate56. In order to promote
HCASMC adhesion, PCU scaffolds were made bioactive through surface modification
with FN. In native blood vessels FN is a glycoprotein of the ECM that serves many
functions. In conjunction with the other components of the ECM, it provides mechanical
support and anchorage for the cells, participates in mechanotransduction and guides the
biological functions of the tissue under both physiological and pathological
conditions47,57-58. FN can also bind many ECM molecules into a continuous network and
binds cells through interactions between the α5β1 and αvβ3 integrins (transmembrane
receptors) and the RGDS (Arg-Gly-Asp-Ser) sequence on the FN molecule59. A host of in
vitro culture studies have shown a correlation between FN and SMC phenotype60-63.
Indeed the presence of a FN substrate shifts SMCs into a synthetic phenotype by
enhancing cell attachment and spreading combined with the formation of an extensive
rough endoplasmic reticulum and large Golgi complex and the loss of myofilaments62.
FN has also shown to have superior results as an adhesion substrate when compared with
others such as vitronectin61. There is also evidence that FN promotes this behavior in
SMCs on 3D substrates. Grenier et al.47 observed increased infiltration, proliferation and
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collagen deposition by HCASMCs on PCU scaffolds compared with uncoated scaffolds.
This was the primary justification for functionalizing PCU scaffolds prior to cell culture.
The secondary purpose for the addition of FN was to partially recreate the ECM of the
arterial media- since the short culture duration is likely insufficient for the formation and
deposition of an extensive network of ECM molecules. As the 3D geometry of the
scaffold makes it difficult to assess cellular morphology and adhesion characteristics, a
2D substrate was instead used to determine the optimal FN density for enhancing
HCASMC attachment. The range of FN concentrations was chosen based on values
reported in literature64-65.
HCASMCs were cultured for 2, 4 or 7 days on FN concentrations of 2, 5 or 10
µg/cm2. Cells were more sparsely distributed on a substrate of 2 µg FN/cm2 (Figure 4.4
A-C) as compared with those cultured on substrates of 5 and 10 µg FN/cm2 (Figure 4.4
D-I) as evidenced by the black areas (bare coverslip). This is likely due to incomplete
coverage of the glass coverslip by FN molecules resulting in cells adhering specifically at
sites where the adhesion sequence is detected by integrins. All subsequent experiments
for HCASMC monocultures and co-cultures employed FN as a basal adhesion protein at
a concentration of 5 µg/cm2 or 5 µg/scaffold.
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Figure 4.4: HCASMCs grown on varying amounts of FN. Representative Fluorescence
microscopy images of HCASMCs cultured on FN coated glass coverslips. HCASMCs were
cultured over 2 (A, D, G), 4 (B, E, H), and 7 (C, F, I) days on 2 (A-C), 5 (D-F) or 10 (G-I)
µg/cm2 FN coated coverslips. F-actin is stained with Alexa Fluor®488 Phalloidin (green) and
nuclei are stained with Hoechst 33342 (blue). Scale bar, 10µm.

It has been acknowledged that scaffold surface area is not 1 cm2 and that 5 µg/cm2
is not analogous to 5 µg/scaffold, nevertheless, it has been proven effective by others21.
Since porosity measurements were not calculated, the exact surface area that is available
for FN adsorption is unknown; as a preliminary experiment it was not necessary to
investigate this topic further.
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4.3.2 Effect of Growth Media Composition on HCASMC and HCAEC
Viability
In addition to determining the optimal FN concentration it was also necessary to
establish the optimal media compositions for maintenance of cells in co-culture. ECs and
SMCs have different nutrient requirements, hence the need for specific nutrient
composition for growth during cell culture. During co-culture of these cells, it was
imperative that the media used in maintaining co-cultures not compromise the viability or
change the behavior of either cell type. Therefore, monocultures were conducted on 2D
substrates of FN-coated glass coverslips for identifying media composition.
As shown in Figure 4.5, HCASMCs exhibited a spindle-like morphology and
were able to maintain a dense population irrespective of media composition. On the other
hand, HCAECs appear to be more stringent in their requirements. HCAECs from panels
D through F in Figure 4.5 displayed a cobblestone morphology which is indicative of a
healthy phenotype65. However, in panel F, which shows HCAECs cultured in SMCspecific media, HCAECs failed to achieve a high enough density to form cell-cell
junctions. Junction formation is critical in achieving two distinct cell layers in co-culture.
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Figure 4.5: HCASMC and HCAEC monocultures in varying growth media compositions.
HCASMCs (A-C) and HCAECs (D-F) were cultured alone for 4 and 2 days respectively, in EGM
(A, D), 1 part EGM and 1 part SmGM (B, E) or SmGM (C, F). F-actin is stained with Alexa
Fluor®488 Phalloidin (green) and nuclei are stained with Hoechst 33342 (blue). Scale bar, 20µm.

HCASMCs may tend to shift to a synthetic phenotype, migrate through the voids
and disrupt the HCAEC layer thereby mimicking the injury response commonly seen
during atherosclerosis. In an engineered vascular substitute this type of cell behavior
would render the construct dysfunctional and upon implantation would result in intimal
hyperplasia, stenosis and graft failure66. The underlying cause for decreased HCAEC
growth in SmGM is likely explained by the absence of essential media components that
are found in EC-specific media (EGM). Examination of the constituents of both SmGM
and EGM reveals that vascular endothelial growth factor (VEGF), recombinant insulinlike growth factor-1 (IGF-1), ascorbic acid and heparin are absent in SmGM. VEGF is
known to have potent mitogenic and angiogenic effects on ECs, a process which is
strongly mediated by heparin67-68. In vitro studies of human umbilical vein ECs have
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suggested that IGF-1 molecules present in the blood in vivo migrate through the
endothelium and act on the subendothelial ECM to have a mitogenic and growth
promoting action on ECs. Furthermore, these studies suggest that IGF-1 may be involved
in the survival and stability of ECs69-70. Finally, the role of ascorbic acid is in the
regulation of nitric oxide (NO) bioactivity. In vivo, NO is produced by ECs and maintains
them in a healthy state. It is also critical for proper control of vascular tone, arterial
pressure, platelet adhesion and SMC proliferation. In fact, the manifestation of vascular
disease may in part be attributed to impaired NO production71. Clearly these components
are vital in sustaining ECs in a healthy proliferative state. Therefore, their absence in
SmGM is the likely cause for reduced HCAECs density in cultures sustained in this
media. These components are also required in the co-culture media to ensure that
HCAECs spread to form a continuous monolayer over the HCASMCs to create a
structure that mirrors the arterial wall. Thus, it was decided that all subsequent cocultures would be sustained in growth media composed of equal parts SmGM and EGM
since under this condition both HCASMCs and HCAECs were able to proliferate and
maintain healthy morphologies.

4.3.3 Long-term HCASMC Monoculture on PCU Scaffolds
The next stage of the study involved examining the interactions between
HCASMCs and PCU scaffolds. In vitro tissue maturation is generally a lengthy process
that spans several weeks. In order for the co-culture model being developed to be
applicable in the fabrication of engineered vascular substitutes, PCU scaffolds must be
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able to support the growth of vascular cells over long periods of time. Specifically they
must enable VSMCs to maintain a healthy state that encourages cell migration, expansion
and ECM deposition. This process should culminate in the formation of a vascular media
that closely resembles the tunica media of the coronary artery. VECs can then be
incorporated to form the tunica intima and regulate the activities of the underlying VSMC
layers. Cell retention on PCU scaffolds is also a good indicator of how these cells would
behave in an in vivo environment; detachment of cells upon implantation may severely
compromise the function of a tissue engineered vascular substitute. In view of this, longterm HCASMC monocultures were investigated.
Figure 4.6 shows the degree to which HCASMCs infiltrated PCU scaffolds over
an 8 and 16 day period. Z-sections were taken at 20 µm increments through the depth of
the scaffold and selected slices are shown at 0 µm, which corresponds to the seeding
surface, 40 µm and 140 µm.
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Figure 4.6: Serial optical sections of long-term HCASMC cultures on PCU scaffolds. Images
of HCASMCs cultured on PCU scaffolds for 8 (A-C) and 16 (D-F) days at depths of 0 µm (A, D),
40 µm (B, E) and 140 µm (C, F) from the seeding surface. F-actin is stained with Alexa
Fluor®488 Phalloidin (green) and nuclei are stained with Hoechst 33342 (blue). Scale bar, 100
µm.

As shown above, HCASMCs adhered to the scaffold struts initially and over time
extended cytoplasmic projections across the entire pore diameter. After 16 days of
culture, the cell population dramatically increased and pores were no longer visible.
Interestingly, a majority of the cell migration and proliferation took place within 40 µm
of the seeding surface of the scaffold. It is possible that the adsorbed FN molecules were
focused within this section of the scaffold resulting in increased initial HCASMC
attachment at these locations. Additionally, because static culture conditions were
utilized, the nutrition and oxygen content of the medium likely becomes depleted with
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increasing depth through the scaffold, thereby affecting cell growth at greater depths.
Although cell infiltration in the vertical direction was slow, a significant difference was
observed between day 8 and day 16 of culture; cell density at 140 µm was much greater
after 16 days as compared with 8 days of culture. Maximal cell penetration at 16 days of
culture was close to 200 µm (Figure Appendix A1); however, only a few cells could be
seen. A study by Grenier et al.45 showed that HCASMCs cultured on PCU scaffolds
achieved a maximum depth of 300 µm after 14 days of culture. Similar to the current
results, the majority of the cell population resided close to the seeding surface of the
scaffold and only one or two cells could be seen at a depth of 300 µm. However, their
presence could not with certainty be attributed to active cell migration45. For instance,
during cell seeding, those cells that show delayed attachment may fall through the pores
to a greater depth within the scaffold before they extend adhesion processes. In the
current study, images were taken at relatively small intervals so the path of cell migration
could be mapped. This confirmed that the presence of cells at 200 µm was a direct result
of active cell migration from the focal planes above. It is possible that some cells were
present at depths greater than 200 µm, but due to limitations placed by the scaffold
thickness or the mounting procedure used, in-focus images could not be taken beyond
this point.
A previous work by our research group46 showed that PCU substrates have the
capacity to support HCASMCs for a period of at least 14 days. In this cited study,
interactions between HCASMCs and PCU films were examined to eliminate any effects
of 3D geometry that PCU scaffolds may impart. Results indicated that HCASMCs do not
attach as readily to bare PCU as compared with Matrigel-adsorbed PCU. Furthermore,
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after 7 days of culture bare PCU films remained sparse46. In a subsequent study45,
interactions between HCASMCs and PCU scaffolds were investigated. In agreement with
the prior results, cells did not attach to bare PCU scaffolds as readily as they did to
Matrigel- coated PCU scaffolds45. Contrary to these results, in the present study,
HCASMCs showed no aversion to bare PCU scaffolds. In fact, examination of Confocal
images showed no noticeable differences in cell density between bare PCU scaffolds and
FN-coated scaffolds after 48 hours of culture (Figure Appendix A2). However, FN was
still employed based on 2D culture results. Moreover, Lin et al.21 noted that HCASMCs
readily adhere to bare PCU scaffolds but do not achieve as dense population as they do
on FN-coated PCU scaffolds after 7 days. Therefore, although noticeable differences
could not be observed over the short culture duration used in the current work, the FN
coating would likely have a long-term effect. Prior to HCASMC seeding, FN-adsorbed
scaffolds were kept hydrated in HBSS to increase their hydrophilicity  which is known
to improve VSMC adhesion, spreading and proliferation72.
Overall, these results reiterate the value of using PCU scaffolds for vascular tissue
engineering. Their ability to support long term growth of HCASMCs is elemental in the
creation of vascular grafts and is a prerequisite for the successive seeding of HCAECs.
This particular experiment was conducted under static conditions using a relatively low
cell density. The seeding of a high HCASMC density and transition to dynamic culture
conditions in a bioreactor would likely enhance and expedite their growth and synthesis
of ECM molecules by improving oxygen, nutrient and waste exchange and by providing
biomechanical cues. In fact experiments involving dynamic culture of HCASCMs on
PCU scaffolds have already been executed with positive results73.
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4.3.4 Effect of Varying HCASMC and HCAEC Seeding Density on Coculture Stability
HCASMCs were seeded at varying densities on PCU scaffolds in order to
investigate its effect on scaffold coverage and ultimately HCAEC attachment. High cell
densities were chosen since the culture duration was short and so would not provide
sufficient time to allow cells to migrate or proliferate extensively. Moreover, low seeding
densities (less than 1x105 SMCs/scaffold) reported in other studies47,74 were not effective
in forming a confluent cell layer over the scaffold surface after 4 days of culture so higher
cell densities were chosen for the present work. HCASMCs cultured alone at three
different densities for 72 hours on PCU scaffolds are shown in Figure 4.7.

Figure 4.7: HCASMCs cultured at varying initial densities for 72 hours on PCU scaffolds.
HCASMCs seeded at initial densities of 250,000/scaffold (A,D), 500,000/scaffold (B,E) and
750,000/scaffold (C,F) shown at 10x (A-D) or 40x (E,F) magnification. Cells are stained with a
the cytoskeletal marker CTG (green) and Hoechst 33342 (blue) for the nuclei. Arrows indicate
scaffold edge. Scale bars, 200µm (A-D) and 20µm (E, F).
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A seeding density of 250,000 cells/scaffold produced scaffolds that were sparse in
some areas and moderately confluent in others. At 500,000 cells/scaffold the majority of
the scaffold surface was covered by a confluent layer of cells. Some areas such as the
scaffold periphery (indicated by arrows in Figure 4.7) had pores that were still visible.
Upon further magnification (Figure 4.7E) it can be seen that confluent areas consisted of
a single monolayer of cells. In contrast, scaffolds cultured with 750,000 cells had densely
packed cells that covered the entire scaffold surface. A corresponding high magnification
image (Figure 4.7F) shows that cells were tightly packed together and appeared to have
multiple layers making them indistinguishable from one another. The presence of
multiple HCASMC layers is also confirmed in Figure 4.8.

Figure 4.8: Serial optical sections of HCASMC cultured on PCU scaffolds. HCASMCs
seeded at an initial density of 750,000/scaffold and cultured for 72 hours on PCU scaffolds.
Selected images from a single image stack are shown at depths of 0 µm (A), 40 µm (B) and 80
µm (C) from the seeding surface. Cells are live-stained with a the cytoskeletal marker CTG
(green) and Hoechst 33342 (blue) for the nuclei Scale bar, 200 µm.

Panels A through C from Figure 4.8 show cell penetration through the scaffold
depth. The high seeding density (750,000 SMCs/scaffold) facilitated the formation of
densely packed layers of cells within (at least) the top 80 µm of the scaffold. In confluent
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areas cells were aligned in parallel to each other and oriented in coordination with
neighboring cells regardless of seeding density; that is, cells throughout the entire surface
seem to be aligned in the same general direction. Interestingly, at low cell densities (such
as those shown in Figure 4.6) cell orientation was guided by the scaffold struts, whereas
at high cell densities, cell alignment was self-guided and coordinated with neighbouring
cells. This created a uniform yet crowded environment rather than clusters of cells that
were randomly aligned. This rearrangement could be an effort to conserve space as cell
density increases and to improve intercellular communication. Unfortunately, the
constituent cells from different cell layers were aligned in different directions (Figure
Appendix A3) ˗ an issue that would likely be resolved under dynamic culture with
mechanical stimulation75-77. With respect to morphology, there appeared to be some
heterogeneity within the scaffold. At seeding densities of 250,000 SMCs/scaffold, sparse
areas of the scaffold contained cells that had a fibroblast-like/ polygonal appearance
neighboring cells that had a spindle-shaped appearance. Furthermore, at high seeding
densities, cells along the seeding surface had a homogenous spindle-shaped morphology
while cells in the underlying layers had a fibroblast-like/ polygonal morphology (Figure
Appendix A3). The spindle-shaped and fibroblast-like morphologies are distinguishing
characteristics of SMCs in the contractile and synthetic phenotypes respectively78.
Whereas cells in the contractile phenotype show a very low proliferative index, cells in
the synthetic phenotype are highly proliferative, migratory and lay down an abundance of
ECM proteins79-80. It is possible that the morphological differentiation is induced by the
scaffold geometry; however, it is unclear why HCASMCs in the upper levels of the
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scaffold undergo this differentiation while cells deep into the scaffold remain in the
synthetic phenotype and continue to populate the scaffold.
Confocal images of co-cultured HCASMCs and HCAECs are shown in Figure
4.9. Images are shown deconstructed into their component channels alongside their
composite images. Cadherin molecules from cell-cell junctions between individual
HCAECs are shown in red, HCASMCs are stained green and nuclei are stained blue.
Mild autofluorescence of PCU lends to its visibility in Figure 4.9D and 4.9G.
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Figure 4.9: HCAECs cultured with varying densities of HCASMCs for 48 hours on PCU
scaffolds. HCASMCs seeded at initial densities of 250,000/scaffold (A,D,G), 500,000/scaffold
(B,E,H) and 750,000/scaffold (C,F,I). HCAEC-cell junctions are stained with VE-cadherin (red)
and HCASMCs are live-stained with the cytoskeletal marker CTG (green).All nuclei are labeled
with Hoechst 33342 (blue). All images are at 10x magnification. Scale bar, 200µm.

Intriguingly, HCAECs preferentially adhered to the HCASMCs over the scaffold
struts. This is evidenced by the fact that areas where the scaffold appears bare in the red
channel (appears black in images) also appear bare in the green channel (appears black or
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faint green in images). Bare areas on the scaffold should have molecules of FN adsorbed
onto their surface and so should promote HCAEC attachment. However, it is possible
that the ECM molecules produced specifically by the HCASMCs provided a better
substrate for HCAEC attachment. The HCAECs also seemed to organize themselves into
a pattern that very closely follows the HCASMC alignment. This is likely due to the
pattern in which the HCASMC-produced matrix molecules were deposited. Not
surprisingly then, scaffolds seeded with 750,000 SMCs resulted in full coverage of the
scaffold surface by HCAECs. Moreover, the HCAECs formed a confluent layer and no
clusters of cells were observed. This observation is in agreement with results obtained by
other investigators81-82. Wallace et al.81 reported alignment and arrangement of ECs in a
similar pattern as the underlying SMCs over which they were cultured. They found that
whereas FN adsorbed onto culture dishes was uniform and diffuse, FN synthesized by
SMCs were organized into fibrils along the cell surface. Therefore, they conjectured that
the pattern of ECM deposition was responsible for the alignment of ECs with the
underlying SMCs81. This was later confirmed in a subsequent study82 where they showed
that the primary protein that controls EC attachment in co-culture is fibrillar FN and is
mediated by it receptor (the α5β1-integrin complex). It is worth mentioning that cocultures on subconfluent HCASMCs (Figure 4.9A, D and G) displayed heterogeneous
attachment of HCAECs. At higher magnifications these cultures had some areas in which
HCAECs were well spread out and aligned with the underlying elongated HCASMCs and
other areas in which HCAECs formed clusters over underlying fibroblast-like
HCASMCs. Moreover, HCAECs in the latter region: were seen adhering to the scaffold
struts, were intermixed with the HCASMC population and had ill-defined junctions
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(Figure Appendix A4). Although the phenotype of the HCASMCs had not been
confirmed at this point it seems as though the HCAECs preferred to adhere to
morphologically differentiated HCASMCs with an elongated, spindle-like morphology.
The pattern of FN deposition by the differentiated HCASMCs versus the synthetic
HCASMCs is likely responsible for this type of attachment pattern. Chaterji et al.83
demostrated that differentiated SMCs produce fibrillar FN while proliferating SMCs
secrete diffuse FN and that this resulted in uniform attachment of ECs to differentiated
SMCs and clustering of ECs on proliferating SMCs. Other reports in literature suggest
that uneven topography results in uneven cell spreading and reduced focal adhesions as
compared with flat surfaces84-85. Together these two factors could account for the
preferred attachment of HCAECs to the relatively horizontal topography (of elongated
HCASMC) rather than the scaffold struts. It has also been suggested that the deposition
of ECM proteins in fibrillar form may be a prerequisite for conserving a quiescent state in
ECs over a long period of time86. Long-term co-culture stability was not investigated in
the present study but the observed arrangement of ECs is akin to that observed in stable
long term co-cultures by other investigators. This suggests that the present 3D co-culture
model could potentially be sustained for extended periods of time.
To verify the existence of an EC monolayer, high magnification optical sections
were taken in the z direction. Images were taken from several different scaffolds to
ensure reproducibility and are shown in Figure 4.10. Images were taken at the seeding
surface (0 µm) and at increasing depths through the scaffold (10 and 20 µm). Since the
HCAECs appear in focus near the seeding surface while the HCASMCs appear in focus
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further into the scaffold, it is clear that the HCAECs were residing above the HCASMCs.
In addition, the HCAECs were organized into a confluent monolayer.

Figure 4.10: Serial optical sections of 750,000 HCASMCs and 200,000 HCAECs co-cultured
for 48 hours. Images taken at depths of 10 µm increments starting at the seeding surface (A,D,G)
and at increasing depths of 10 µm (B,E,H) and 20 µm (C,F,I). VE-cadherin (red) staining shows
HCAEC-cell junctions while HCASMCs are stained with a cytoskeletal marker CTG (green). All
nuclei are labeled with Hoechst 33342 (blue). Scale bar, 20µm.
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Examination of the bottom right corner of Figure 4.10A shows HCAECs that are in
focus. Upon inspection of the same area in Figures 4.10B&C it can be concluded that
there were no HCAECs inhabiting that area at 10 or 20 µm depths. Similar observations
can be made for all other areas of the images shown in Figure 4.10 thus proving that
HCAECs were organized into a single monolayer. Junctions between individual
HCAECs were well-defined as demonstrated by the intense VE-cadherin staining. VEcadherin is a major component of EC-cell junctions and is the primary determinant of
contact integrity. Its presence is critical in controlling vascular permeability to cells and
other substances. Unlike other EC junction molecules (such as PECAM) cadherins are
linked to the actin cytoskeleton through catenins thereby strengthening intercellular
contacts. VE-cadherin also mediates cell proliferation through contact inhibition via
various signaling processes87-88. This suggests that the formation of a confluent
monolayer contributes to quiescence in ECs. The presence of intense VE-cadherin
staining in the current 3D co-cultures is a positive sign suggesting that the HCAECs are
in a healthy quiescent state with strong junctions that inhibit overgrowth of HCASMCs
into the HCAEC layer and that the structure as a whole is representative of a native
artery. This property is important for tissue engineered vascular substitutes since wide
junctional gaps may result in dysfunction causing the tissue to behave as a pathological
vessel66. The alignment of the underlying HCASMCs in Figure 4.10 is difficult to make
out partly due to the high cell density and partly due to the varying directions in which
different layers of HCASMCs are aligned. It seems as though some of the HCASMCs
were organized perpendicular to the direction of the HCAECs as seen in vivo.
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Realignment of HCAECs in co-culture has been observed by other investigators81 as a
result of reorganization of the ECM between the two cell layers.
A study by Lavender et al.65 examining the effects of culturing ECs on
proliferating SMCs showed that ECs adhered with lower efficiency and attached as
clusters over the underlying SMCs, failing to form a confluent monolayer. In addition,
the EC population continuously declined and after 6 days in co-culture, only few cells
were left. In comparison ECs seeded onto a confluent, quiescent layer of SMCs attached
uniformly and formed a confluent layer that could be sustained for at least 10 days65.
Chaterji et al.83 reported similar observations. It should be noted that in both
investigations serum withdrawal was used to induce a quiescent, contractile phenotype in
SMCs. Although the present study did not induce contractility in the HCASMCs prior to
HCAEC seeding, varying HCASMC densities were used to examine their effects on EC
attachment. In co-cultures employing sub-confluent HCASMC densities it was observed
that although HCAECs preferentially adhered to the underlying HCASMCs, the
attachment was non-uniform. Over longer culture durations this could result in HCAEC
detachment as well as heterogeneous HCASMC phenotypes as reported in literature65. It
is also likely that there would be overgrowth of one cell layer into the other resulting in
the loss of a distinct layered structure. Therefore, in order to avoid this undesirable
outcome, a seeding density of 750,000 – which resulted in multiple dense and confluent
layers of HCASMCs - was chosen for subsequent experiments.
Similar experiments were carried out to determine the effect of varying HCAEC
seeding density on co-culture stability. A confluent endothelium has important
implications for tissue engineered vascular substitutes. In vivo, the endothelial monolayer
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regulates the transport of molecules into the vascular bed, prevents thrombosis, and
regulates the growth and function of the underlying SMCs89-91. Loss of an intact
endothelium can result in intimal hyperplasia – characterized by migration and
proliferation of SMCs92. Similar pathologies have been observed in vascular grafts
lacking an intact endothelium. This exemplifies the importance of an intact confluent
endothelium in the maintenance of a differentiated SMC phenotype. Studies conducted
by Chaterji et al.83 revealed that culturing of SMCs with a subconfluent layer of ECs
induced a hyperplastic state and loss of differentiation markers after 48 hours. On the
other hand, a confluent layer of ECs permitted co-culture stability for 40 days83. In the
present work, HCAECs were seeded at densities of 200,000 cells/scaffold or 400,000
cells/scaffold. Since cultures utilizing 200,000 ECs/scaffold were successful in achieving
a confluent monolayer over the entire scaffold surface, the data for the experiment
involving 400,000 cells/scaffold is not shown. With the exception of one notable
difference (described below), the co-culture structure appeared identical irrespective of
HCAEC seeding density and so a seeding density of 200,000 ECs/scaffold was used in
subsequent experiments. Figure 4.11 shows images taken from co-cultures employing
400,000 ECs/scaffold. Interestingly, there appeared to be tubular structures at the top
surface of the scaffold. Though difficult to conclusively assert, some areas of these
structures are composed of both HCASMCs and HCAECs and somewhat resemble an
inverted artery wall with a very narrow lumen (indicated by arrows in Figure 4.11). A
possible explanation for the rearrangement of cells into these structures is the
overcrowding of cells resulting from an excess of HCAECs during seeding. By virtue of
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the nature of ECs, and as a result of contact inhibition, the excess cells likely preferred
arrangement into tubular structures rather than a second monolayer.

Figure 4.11: Formation of tubular structures in HCASMCs co-cultured with excess
HCAECs. Images taken at the seeding surface (0 µm) of scaffolds used for culturing 750,000
HCASMCs and 400,000 HCAECs. HCASMCs are stained with CTG (green) while HCAEC-cell
junctions are stained with VE-cadherin (red). All nuclei are labeled with Hoechst 33342 (blue).
Arrow indicates the hollow lumen of the tubular structures. Scale bar, 20 µm.

These cells appear to be arranged end-to-end as evidenced by the gaps between
individual nuclei; this organization is typically seen in in vitro angiogenesis models93-95.
Another structural feature that was observed in these cultures (and other monocultures
and co-cultures) was the hill-and-valley growth pattern of HCASMCs. Because HCAECs
(likely) attached to the in situ fibrillar FN molecules, they adhered to the underlying
HCASMCs regardless of their topography and so the confluence of the HCAEC
monolayer was unaffected. Hill-and-valley formation is characteristic of SMCs that have
been monocultured and has been noted by several investigators96-98. In the cited studies,
the hill-and-valley growth pattern was inhibited in co-culture by ECs. However, these
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studies utilized a bi-layered co-culture configuration in which ECs and SMCs were
cultured on opposite sides of a PET membrane and were cultured together for durations
exceeding 48 hours. On the other hand, Powel et al.96 showed that whereas hill-andvalley formation was arrested in co-cultures using a bi-layer format, the same was not
observed in co-cultures using a monolayer format (ECs grown directly over SMCs). It is
possible that extended co-culture durations in the present work would result in the
rearrangement of cells into a more planar structure but the use of dynamic culturing
would likely correct this problem prior to the initiation of co-culture99.
The formation of multiple confluent SMC layers and a monolayer of ECs are
critical in the replication of both the normal arterial structure and physiological functions.
In vivo, ECs line the innermost surface of the artery wall, creating a barrier between the
blood and the subendothelial tissue. This lining consists of a confluent cell monolayer
that if disrupted can lead to a pathogenic response such as that seen in atherosclerosis.
Therefore, in the current study, it was important to achieve confluent distinct layers of
HCAECs and HCASMCs.

4.3.5 Effect of Varying Matrigel Concentration on HCAEC Attachment
Matrigel was incorporated into co-culture constructs in an attempt to mimic the
basement membrane found in native blood vessels. In vivo, the ECs that line the lumen of
the vessel are bound to a substrate of ECM molecules (collagen IV, heparin sulfate
proteoglycans and the glycoproteins LN and nidogen/entactin) that comprise the
basement membrane95. These proteins play a role in maintaining the stability of the
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vessel, in regulating EC behavior and in sustaining the ECs in a well-differentiated
state94. In vitro studies have tested the effects of these proteins (alone or in combination)
on EC attachment and differentiation. For instance, culturing of rat microvascular ECs on
substrates of FN, collagen III or collagen I enhances proliferation while culturing on
substrates of LN or collagen IV (basement membrane components) promote attachment
and differentiation94. Matrigel has been extensively used to promote morphological
differentiation of ECs93-94. Tubule formation in these and other studies95 has been
attributed to the actions of LN. LN is the primary component of Matrigel followed by
collagen IV, heparin sulfate proteoglycans, entactin and nidogen. Therefore, it was
hypothesized that a low concentration of Matrigel would enhance HCAEC attachment
and would maintain a (quiescent) differentiated state through activities mediated by LN.
As per the manufacturer’s instructions, a highly diluted solution of Matrigel was applied
to bare PCU scaffolds and also to co-cultures in order to avoid HCAEC capillary
formation while still promoting cell attachment. The formation of capillaries in this coculture model would be disadvantageous in that it would firstly create a heterogeneous
structure and may secondly result in heterogeneous signaling and cell behaviors- thereby
hampering our ability to study the interactions between HCAECs and HCASMCs in
direct contact in a controlled manner. Two different dilutions were investigated to
determine the extent to which Matrigel promoted HCAEC attachment. HCAEC
distribution on Matrigel-coated scaffolds and Matrigel-incorporated co-cultures are
shown in the Figures 4.12 and 4.13 respectively.
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Figure 4.12: Effect of Matrigel on HCAEC attachment to PCU. ECs cultured for 48 hours on
PCU scaffolds containing no Matrigel (A,D), Matrigel at 1:50 dilution (B,E) and Matrigel at
1:100 dilution (C,F) at 10x (A-C) and 40x (D-F) magnifications. Cell-cell junctions are stained
with VE-cadherin (red) and nuclei are labeled with Hoechst 33342 (blue). Scale bars, 200µm (AC), and 20µm (D-F).

Images of monocultures show that HCAECs readily adhered to the scaffold in all
instances and no areas lacking cells could be seen. On Matrigel-coated scaffolds, cells
appeared as though they were more densely packed together so the addition of Matrigel
may have mildly promoted cell attachment. In addition, there were a greater number of
cells exhibiting intensely stained VE-cadherin based junctions on scaffolds coated with
Matrigel. This is not surprising since LN promotes a differentiated phenotype in which
ECs form well-defined junctional complexes (a characteristic of native vascular ECs).
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When comparing the images from monocultures (Figure 4.12) to images from cocultures (Figures 4.10 and 4.13) a difference in morphology, alignment and cadherin
staining can be discerned. HCAECs cultured alone on scaffolds had a cobblestone shape
where as HCAECs cultured over SMCs had an elongated shape. This finding is consistent
with literature reports which have shown a shift in EC morphology from cobblestone in
monoculture to elongated in co-cultures with differentiated SMCs65,

81, 83, 100

. Whereas

HCAECs showed no particular pattern of alignment in monocultures, co-cultured cells
were relatively aligned in the direction of the underlying HCASMCs. As discussed
earlier, this could be attributed to the organization of the fibrillar FN that is produced by
HCASMCs. Lastly, HCAECs in co-culture stained more intensely for VE-cadherin than
HCAECs cultured alone. This observation is also consistent with reported findings where
an increase in tight junction formation in co-cultures of ECs and SMCs were observed
compared with monocultured ECs101. Although tight junctions are not the same as
cadherins junctions, they are a measure of contact integrity.
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Figure 4.13: Effect of Matrigel on HCAEC attachment in co-culture. HCAECs cultured for
48 hours on HCASMC-scaffold constructs containing no Matrigel (A,D), Matrigel at 1:50
dilution (B,E) and Matrigel at 1:100 dilution (C,F) at 10x (A-C) and 40x (D-F) magnifications.
HCAEC-cell junctions are stained with VE-cadherin (red) while HCASMCs are stained with the
cytoskeletal marker CTG (green). All nuclei are labeled with Hoechst 33342 (blue). Scale bars,
200µm.

Images of co-culture constructs employing a medial layer of Matrigel are shown
in Figure 4.13. Since the effects of Matrigel were not drastic in HCAEC monocultures it
was not expected that Matrigel addition in co-culture would have any profound effects.
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Consistent with this, no differences could be seen among the three conditions with
respect to HCAEC attachment and density. This may not be surprising since it has
already been discussed that ECs prefer attachment to extracellular proteins from an in situ
source (SMCs) rather than an exogenous source. Moreover, if the HCASMCs have
already deposited enough fibrillar FN by the onset of co-culture to achieve full coverage
of HCAECs then Matrigel’s presence should not have any added benefit (with respect to
initial attachment). Matrigel (at a 1:100 dilution) was still incorporated in the experiments
to follow since firstly, it did not produce any adverse effects, secondly, it may have had
some benefit (such as creating a more extensive medial ECM) that could not be observed
through gross examination, and finally, Matrigel may be required to maintain monolayer
integrity over longer culture durations46. The latter point has been shown to be true in
monocultures of ECs on PCU films so it may or may not be applicable to this scenario.

4.3.6 Conditions Resulting in Successful Co-culture
The conclusions of all above experiments are summarized in Table 1 below.
Table 1: Summary of conditions required for successful co-culture

Factor

Preferred condition

Fibronectin concentration

5 µg/scaffold

Co-culture growth media composition

1 part EGM and 1 part SmGM

HCASMC seeding density

750,000 cells/scaffold

HCAEC seeding density

200,000 cells/scaffold

Matrigel dilution

1:100 dilution in growth media
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These are the culture conditions that resulted in the formation of a healthy and stable 3D
co-culture construct. As mentioned previously, it was important to ascertain these optimal
conditions in order to study the interactions between HCAECs and HCASMCs with
relevance to the interactions in native states.

4.4 Protein Expression Levels in HCASMCs and HCAECs
from 3D Co-culture
One of the main objectives of this study was to examine any phenotype changes
that HCASMCs may undergo in the presence of HCAECs. Up until this point, results
were largely qualitative observations made based on confocal images. HCASMCs
cultured alone on PCU scaffolds had mixed morphologies with cells in the upper layers
having an elongated, spindle-like shape characteristic of the contractile phenotype while
cells deeper in the scaffold displayed a fibroblast-like morphology characteristic of the
synthetic phenotype (Figure Appendix A3). The initiation of co-culture did not produce
any noticeable changes in HCASMC morphology. Based on reports from literature, we
had hypothesized a phenotypic shift from synthetic in monocultures to contractile in cocultures77,97,102. However, HCASMCs on the seeding surface of the scaffold already
displayed a spindle-like morphology and so if the presence of ECs did activate a
contractile phenotype shift, morphological changes would not be observed. However, the
contractile morphology of the HCASMCs, may not necessarily correlate with the
contractile phenotype, that is, the elongated HCASMCs may have been in a nonproliferative state without a simultaneous expression of contractile marker proteins. For
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instance, Grenier et al.47 noticed most HCASMCs cultured on PCU scaffolds to be
elongated but cells expressing contractile marker proteins were found next to cells devoid
of any contractile marker protein expression. Similarly Lin et al.21 observed a
heterogeneous expression of contractile protein markers in elongated HCASMCs cultured
on PCU scaffolds. Therefore, qualitative observations alone cannot be used to
definitively ascertain the phenotype of the SMCs. For this reason it was necessary to
examine the relative contractile protein expression levels to deduce if there was a
differential regulation between HCASMCs in monoculture and HCASMCs in co-culture.

4.4.1 Effect of Co-culture on Protein Expression Levels
At the start of this study we hypothesized that HCASMC phenotype would be
modulated from synthetic in monoculture to contractile in co-culture with HCAECs. This
speculation was based on reports generated by other investigators77,97,102. For example, in
a 2D direct co-culture system, Chaterji et al.83 described a dramatic increase in the
expression of SM-α-actin by SMCs in co-culture compared to expression levels in
monoculture and a less noticeable increase in calponin. Wallace et al.81 noticed a distinct
upregulation of calponin in co-cultured SMC in a similar 2D direct co-culture system.
However, there have not been any studies (that we are aware of) that have focused
exclusively on the interactions between SMCs and ECs in a 3D environment in the
absence of other stimuli (ie. mechanical or biochemical). Furthermore, the mechanisms
regulating their interactions are not well understood. Therefore, in order to create a
functional vascular substitute that closely mimics the native artery it is important to
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understand the interactions between the individual cellular components of the substitute
so that the tissue engineered vascular substitute can be optimized prior to implantation.
In preliminary screening experiments, the cell-scaffold constructs were directly
lysed to extract proteins for Western blot analysis. However, this proved to be
insufficient because protein lysates from both cell types were mixed in the co-culture
condition, thus limiting our ability to determine which cell type was contributing to the
expression levels. This led to the use of PECAM –conjugated magnetic beads for the
separation of HCAECs from HCASMCs. PECAM is a cell surface molecule that is
expressed by ECs, platelets and leukocytes (among others) and is not expressed by
SMCs87. Cells were first detached using trypsin which has been shown to be effective in
removing cells from PCU scaffolds21,47. The cell mixture was then incubated with
PECAM- conjugated magnetic beads to facilitate binding of HCAECs to the beads. The
beads were then separated from the remaining suspension (containing HCASMCs).
Separation efficiency was tested to ensure cell extracts were not contaminated to any
significant extent that it would limit Western blot analysis. Following SDS-PAGE,
membranes were probed for the following proteins: SM-α-actin, calponin, Notch3,
Jagged1 and GAPDH. SM-α-actin and calponin are SMC differentiation markers that are
known to be upregulated in the contractile phenotype21-22 while Notch3 and Jagged1 are
involved in a mechanism pathway that has been implicated in the regulation of SMC
phenotype2-3,5-6,8-9,103. GAPDH is a housekeeping gene that is commonly used as an
internal control. It is expressed at a relatively constant level regardless of experimental
conditions and as such it provides a good method of normalizing quantitative gene/
protein expression data104. Normalized protein expression levels are shown with their
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corresponding blots in Figure 4.14. Four culture conditions were compared: SMCs
cultured alone (SM), SMCs co-cultured and subsequently separated (SM cc), ECs cocultured and subsequently separated (EC cc) and ECs cultured alone (EC).

Figure 4.14: HCASMC and HCAEC protein expressions levels after 48 hours of co-culture
on PCU scaffolds. Expression levels of Jagged1 (A), Notch 3 (B), SM α-actin (C) and Calponin
(D) in HCASMCs and HCAECs cultured alone or together. Asterisks indicate statistically
significant data (p<0.05). Nomencalture: EC (HCAECs from monoculture), EC cc (HCAECs in
co-culture with HCASMCs and separated), SMC cc (HCASMCs in co-culture HCAECs and
separated) and SM (HCASMCs from monoculture).

When comparing HCASMCs cultured alone to HCASMCs from co-culture it is
clear that co-culture induced a significant upregulation in contractile proteins (p<0.05).

105
Surprisingly, even basal levels of contractile proteins could not be detected in HCASMCs
cultured alone. SM-α-actin and calponin are known to be present in the early to mid
stages of VSMC differentiation25,105-106. This suggests that even after 4 days of HCASMC
monoculture cells either did not begin a transition to the contractile phenotype or that
very small populations of cells were expressing contractile markers in monoculture but
these proteins were not at a high enough concentration to allow detection. Previous work
involving the culture of HCASMCs on PCU scaffolds described some expression of
contractile protein markers21,47. However, these studies involved longer culture durations
or much larger samples from which proteins were collected. The absence of SM-α-actin
and calponin from HCAECs in co-culture indicates that the separation protocol used was
highly efficient.
As part of the hypothesis that was earlier stated, we also speculated that the any
observed modulations in HCASMC phenotype may in part be due to the actions of
Notch3 and Jagged1. The Notch family of membrane-bound receptors has been shown to
play a critical role in vascular development and remodeling. These receptors are part of a
short-range signaling pathway that involves membrane-bound receptors and ligands that
are expressed on adjacent cells5. Four Notch receptors (Notch1 to 4) and their ligands
(Delta-like 1 and 2 and Jagged1 and 2) are expressed in ECs and SMCs in differing
combinations2. Notch 3 is the predominant receptor that is expressed in VSMCs while
Jagged1 is prominently expressed by vascular ECs and has also been detected in arterial
SMCs1-4. Their crucial roles are exemplified in diseases such as Alagille syndrome and
CADASIL which are consequences of mutations in Jagged1 and Notch33. Binding of the
Notch receptor with its ligand (Jagged1) results in proteolytic cleavage of the receptor’s
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intracellular domain which then translocates to the nucleus. This signal transduction
pathway involves several effectors and ultimately prompts differentiation in VSMCs5. A
host of in vivo and in vitro studies have demonstrated a vital function of Jagged1 in
regulating SMC differentiation2,5-9. These studies formed the basis for our examination of
expression levels of Notch3 and Jagged1 in HCAEC and HCASMCs.
As shown in Figure 4.14, expression of both Notch3 and Jagged1 were
upregulated in co-culture, indicated by the blots and the corresponding bar graph. As
expected, Jagged1 was predominantly expressed by HCAECs and to a lesser but
detectable degree by HCASMCs. Unexpectedly, there was also no basal expression of
Notch 3 or Jagged1 in monocultures. In the case of Jagged1, the differential expression
was not as dramatic as in the other proteins. This is evidenced by the intensity of the
bands on the Western blots as well as the scales used in the graphs. The absence of
Jagged1 and Notch3 in monocultures was not in agreement with findings reported in
literature. For instance, in a study by Ying et al.25 Jagged1 and in particular Notch 3 were
noticeably expressed in HCAECs and HCASMCs respectively. Similarly Liu et al.2
noticed a robust basal expression of Notch3 and Jagged1 in HCASMCs. In both cases,
the expression of Notch3 in monocultured SMCs was accompanied by detectable
amounts of SM-α-actin and calponin. In spite of these differences, the general trend in the
current study was similar to that seen in the aforementioned work; co-culture augmented
the expression of all four target proteins: Jagged1, Notch3, SM-α-actin and calponin.

4.4.2 Effect of siRNA Knockdown of Jagged1 on Protein Expression
Levels
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At this point, no correlations between the target proteins could be inferred from
the data. Therefore, the next logical step was to abrogate a component of the Notch
signaling pathway and observe the downstream effects on differentiation markers. To this
end, we knocked down the expression of Jagged1 in HCAECs using siRNA. It has
previously been shown that EC derived Jagged1 and a model that enables heterotypic
cell-cell contact are both requisites for enhancing Notch3 expression and subsequent
contractile protein expressions25. One day prior to the initiation of co-culture, HACECs
were transfected with either Jagged1 siRNA or control siRNA. 20 hours later, HCAECs
were seeded over HCASMCs and cultured for 48 hours as per the co-culture protocol
described in Chapter 3. Transfection efficiency was tested to ensure sufficient
knockdown of Jagged1 in HCAECs.
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Figure 4.15: Effect of siRNA knockdown of Jagged1 on protein expression levels in coculture. Expression levels of Jagged1 (A), Notch3 (B), SM α-actin (C) and calponin (D) in
HCASMCs and HCAECs cultured alone or together. Asterisks indicate statistically significant
data (p<0.05). Nomenclature: EC siD (control siRNA-transfected HCAECs in monoculture), EC
siJAG (Jagged1 siRNA-transfected HCAECs in monoculture), EC cc siD (control siRNAtransfected HCAECs in co-culture with SMCs and separated), SM cc siD (HCASMCs cocultured with EC siD and separated), EC cc siJAG (Jagged1 siRNA-transfected HCAECs in coculture with SMCs and separated) and SM cc siJAG (HCASMCs co-cultured with EC siJAG and
separated)

As shown in the Figure 4.15 Jagged1 in siRNA transfected HCAECs was not
detected in neither monoculture nor co-culture indicating successful knockdown of
Jagged1. As expected, the result of culturing HCASMCs with Jagged1 siRNA
transfected- HCAECs was a significant (approximately three-fold) downregulation of
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Notch3 in HCASMCs. Interestingly, although the reduction in SM-α-actin expression
was significant it was not as marked. This was surprising since Notch has been shown to
directly target SM-α-actin expression23.In comparison the reduction in calponin
expression was more than two-fold. Nonetheless, it is possible that because Notch3
expression was not entirely diminished in co-culture with Jagged1 siRNA-transfected
HCAECs, a low level of Notch activation was sufficient in propagating its own
expression and that of α-actin. Using a series of Notch pathway inhibitors and activators,
Liu et al. showed that Notch3 receptor activation is essential in promoting further Notch3
expression. They suggested that initial Notch3 activation by Jagged1-presenting ECs
initiates an autoregulatory positive feedback loop in SMCs whereby the SMCs increase
expression of Notch3 and Jagged1, thus maintaining themselves in a differentiated state2.
Hence, the sustained expression of Notch3 and SM-α-actin in the present experiment may
be a result of initial Notch3 activation by a few Jagged1-expressing HCAECs and
subsequent amplification of this signal by homotypic cell-cell interactions between
HCASMCs that are expressing Notch3 and neighboring HCASMCs that are expressing
Jagged1. It may be of interest to examine if the expression of these proteins is timedependant. Perhaps the expression of both Notch3 and SM-α-actin are considerably
abrogated within the first few hours of co-culture but are recovered overtime.
Furthermore, because SM-α-actin expression precedes that of calponin during the process
of SMC differentiation, calponin expression may be recovered more slowly.
Alternatively, it is possible that other regulatory mechanisms were in place that
counteracted the downregulation of SM-α-actin. For instance, the protein kinase A and
phosphoinositide 3-kinase/Akt pathways have also been implicated in EC-induced
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VSMC differentiation. Fetalvero et al.107 reported an increase in SM-α-actin, calponin,
MHY and h-caldesmon expression in VSMCs cultured with iloprost. They showed that
iloprost activated the VSMC-expressed prostacylin receptor and in turn activated the
protein kinase A pathway. Iloprost is an analog of prostacyclin which is an EC-derived
molecule that is important in the maintenance of a differentiated VSMC phenotype in
vivo107. In a bilayered EC-SMC co-culture model, Brown et al.108 demonstrated that
bovine aortic ECs augmented the expression of differentiation markers in bovine aortic
SMCs through activation of the phosphoinositide 3-kinase/Akt signaling pathway in
SMCs. Therefore, these signaling pathways are likely activated simultaneously by ECexpressed factors so disruption of one pathway may not result in complete suppression of
VSMC differentiation markers. This is especially true if the signal strength of one of
these pathways is far greater than the signal strength of another’s. A comparative study to
determine the extent to which each of these pathways plays a role in HCASMC
differentiation may be helpful in revealing the optimal method through which the
phenotype of these can be modulated. Although it has been shown, in the present study
and in others, that direct co-culture of VECs and VSMCs is a requirement for Notch
signaling, the same may not be true for Akt activation108 or prostacylin receptor
activation107. Incorporation of multiple factors into PCU scaffolds and into the co-culture
model described in this study could conceptually have a synergistic effect on HCASMCs
differentiation.
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Chapter 5 – Conclusions and Future
Directions
5.1 Conclusions
The present study involved the examination HCASMCs phenotype modulation in
the presence of HCAECs. Initial exploratory experiments that involved the assessment of
gene expression in HCAECs and HCASMCs in 2D cultures indicated that the contractile
phenotype can be induced via the Notch3 signaling pathway only when HCASMCs are
directly cultured with HCAECs. Soluble Jagged1 protein and Jagged1-immobilized
Dynabeads failed to upregulate SM-α-actin and calponin gene expression levels;
however, siRNA knockdown of Jagged1 in HCAECs demonstrated a direct link between
HCAEC-expressed Jagged1 and contractile gene expression in HCASMCs. This led to
the investigation of direct co-culture of HCAECs and HCASMCs on 3D PCU scaffolds.
In order to create a cell-scaffold construct that mimics the in vivo artery structure a series
of experiments were carried out to optimize the culture conditions. It was determined that
a FN concentration of 5 µg/cm2 resulted in increased HCASMCs attachment and that a
growth media composition of 1 part SmGM and 1 part EGM enabled the maintenance of
high HCASMC and HCAEC densities. Long-term HCASMC cultures on PCU scaffolds
showed that cells were able to proliferate and maintain a healthy morphology which
illustrated the value of using PCU scaffolds as a support structure for engineered vascular
substitutes. Short-term cultures were then carried out using high HCASMC densities. A
seeding density of 750,000 HCASMCs/ scaffold resulted in the formation of a dense,
confluent HCASMCs layer which facilitated the formation of a confluent layer of
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HCAECs. Matrigel was then incorporated into the co-culture model to mimic the
basement membrane matrix that is found underlying the endothelium of native blood
vessels. The addition of Matrigel did not produce a significant difference, with respect to
HCAEC attachment, however, a dilution of 1:100 (Matrigel: growth media) was still
employed in subsequent cultures. To conclusively affirm the phenotype of HCASMCs in
co-culture with HCAECs, Western blot was performed and protein expression levels
were analyzed. It was demonstrated that co-culture of HCASMCs with HCAECs
upregulated the expression of the contractile proteins SM-α-actin and calponin as well as
Notch3 and Jagged1. Gene knockdown of Jagged1 in HCAECs using siRNA established
a direct link between the Notch3 signaling pathway and HCASMC phenotype. A
reduction in Jagged1 expression by HCAECs in co-culture resulted in decreased
expression of SM-α-actin and calponin by HCASMCs in co-culture.
These results demonstrate that co-cultures of HCAECs and HCASMCs can be
successfully sustained on PCU scaffolds and that HCAECs modulate HCASMC
phenotype in 3D cultures via the Notch3 signaling pathway. These findings are highly
relevant in the context of vascular tissue engineering. The success of a tissue engineered
vascular substitute is highly dependent on the phenotype of the VSMCs that reside within
it. Based on these findings the Notch3 signaling pathway can potentially be exploited for
regulating the phenotype of VSMCs during in vitro tissue maturation. This could be
achieved through augmenting the expression of one or more of the components involved
in the Notch3 signaling pathway.
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5.2 Future Directions
Follow-up studies should be performed to determine the long term effect of
HCAEC on HCASMC phenotype. It would be undesirable for HCASMCs to revert back
to a synthetic phenotype so it should be verified that HCAECs are capable of maintaining
HCASCMs in a contractile phenotype for periods greater than 48 hours. Furthermore, it
would be beneficial to perform a comparative study to examine the relative effects of
different phenotype regulatory molecules and mechanisms. These include illoprost and
TGF-β1 which have both been shown to induce the contractile phenotype in VSMCs1-3.
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Appendix – Supplementary Data

Figure A1: Cell infiltration in long-term cultures of HCASMCs on PCU scaffolds. Images of
HCASMCs cultured on PCU scaffolds for 8 (A, C, E) and 16 (B, D, F, G, H) days at depths of 0
µm (A, B), 40 µm (C, D), 140 µm (E, F), 180 µm (G) and 200 µm (H) from the seeding surface.
F-actin is stained with Alexa Fluor®488 Phalloidin (green) and nuclei are stained with Hoechst
33342 (blue). Scale bar, 100 µm.
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Figure A2: HCASMCs cultured for 72 hours on PCU scaffolds coated with varying amounts
of FN. HCASMCs cultured on PCU scaffolds coated with 0 (A), 5 (B) and 10 (C) µg of
FN/scaffold. Cells are live-stained with a the cytoskeletal marker CTG (green) and Hoechst
33342 (blue) for the nuclei Scale bar, 200 µm
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Figure A3: Serial optical sections of HCASMCs cultured for 72 hours on PCU scaffolds at a
density of 750,000 cells/scaffold. Selected images from a single image stack are shown at depths
of 0 µm (A), 10 µm (B), 20 µm (C), 30 µm (D), 40 µm (E), 50 µm (F), 60 µm (G), 70 µm (H), 80
µm (I)from the seeding surface. Cells are live-stained with a the cytoskeletal marker CTG (green)
and Hoechst 33342 (blue) for the nuclei Scale bar, 20 µm.
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Figure A4: 48-hour co-cultures of HCAECs with sub-confluent HCASMCs on PCU
scaffolds. HCAECs can be seen forming clusters (A), intermixing with the HCASMC layer (B)
and adhering to the scaffold struts (C). PCU scaffold is shown as mild green fluorescence in panel
C. HCASMCs are stained with CTG (green) while HCAEC-cell junctions are stained with VEcadherin (red). All nuclei are labeled with Hoechst 33342 (blue). Scale bar, 20 µm.
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